• Assay Type
    Solid Phase Sandwich ELISA
  • Format
    96-well strip plate
  • Assay Length
    4.5 hours
  • Sample Type & Volume Required Per Well
    Cell Culture Supernates (200 uL), Serum (100 uL), EDTA Plasma (100 uL), Heparin Plasma (100 uL), Citrate Plasma (100 uL)
  • Sensitivity
    9 pg/mL
  • Assay Range
    15.6 - 1,000 pg/mL (Cell Culture Supernates), 31.2 - 2,000 pg/mL (Serum, EDTA Plasma, Heparin Plasma, Citrate Plasma)
  • Specificity
    Natural and recombinant human VEGF. This assay cross-reacts 67% with Canine VEGF and 82% with Feline VEGF.
  • Cross-reactivity
    < 0.5% cross-reactivity observed with available related molecules.Cross-species reactivity observed with 1 or more species tested.
  • Interference
    Interference observed with 1 or more available related molecules.
Control Available
Product Summary
The Quantikine Human VEGF Immunoassay is a 4.5 hour solid phase ELISA designed to measure VEGF165 levels in cell culture supernates, serum, and plasma. It contains Sf 21-expressed recombinant human VEGF165 and antibodies raised against the recombinant protein. Results obtained for naturally occurring human VEGF and recombinant human VEGF121 showed linear curves that were parallel to the standard curves obtained using the Quantikine Human VEGF Immunoassay standards. These results indicate that this kit can be used to determine relative mass values for natural human VEGF.

Precision
Intra-Assay Precision (Precision within an assay) Three samples of known concentration were tested on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays) Three samples of a known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of kit components.
Cell Culture Supernates
Intra-Assay Precision Inter-Assay Precision
Sample123123
n202020404040
Mean29.112353132.8128495
Standard Deviation1.9518.42.86.433
CV%6.54.13.58.556.7

Serum, EDTA Plasma, Heparin Plasma, Citrate Plasma
Intra-Assay Precision Inter-Assay Precision
Sample123123
n202020404040
Mean53.723591064.52501003
Standard Deviation3.610.646.25.717.461.7
CV%6.74.55.18.876.2

Recovery

The recovery of human VEGF spiked to levels throughout the range of the assay in various matrices was evaluated.

Sample Type Average % Recovery Range %
Cell Culture Media (n=5) 102 95-111
Citrate Plasma (n=5) 100 88-113
EDTA Plasma (n=5) 97 82-113
Heparin Plasma (n=5) 93 82-102
Serum (n=5) 102 92-115
Linearity
To assess the linearity of the assay, samples spiked with high concentrations of VEGF were serially diluted with the appropriate Calibrator Diluent to produce samples with values within the dynamic range of the assay.
Human VEGF Quantikine ELISA Kit
Preparation and Storage
  • Storage
    Store the unopened product at 2 - 8 °C. Do not use past expiration date.
Background: VEGF
VEGF (Vascular endothelial growth factor) is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is required for regulating the proliferation, migration, and survival of embryonic endothelial cells and during wound healing and the female reproductive cycle in adults. Pathologically, it is involved in tumor development and tumor vascular leakage. VEGF binds to VEGF R1/Flt-1, VEGF R2/Flk-1/KDR, and Neuropilin-1. Multiple forms of VEGF are generated by alternative splicing and proteolysis.
    • Long Name
      Vascular Endothelial Growth Factor
    • Entrez Gene IDs
      7422 (Human); 22339 (Mouse); 83785 (Rat); 281572 (Bovine); 403802 (Canine); 493845 (Feline); 30682 (Zebrafish);
    • Alternate Names
      MVCD1; VAS; vascular endothelial growth factor A; Vascular permeability factor; Vasculotropin; VEGFA; VEGF-A; VEGFMGC70609; VPF; VPFvascular endothelial growth factor;
    Related Research Areas
    Assay Procedure
    Refer to the product for complete assay procedure.

    Bring all reagents and samples to room temperature before use. It is recommended that all samples, standards, and controls be assayed in duplicate.
    1.   Prepare all reagents, standard dilutions, and samples as directed in the product insert.
    2.   Remove excess microplate strips from the plate frame, return them to the foil pouch containing the desiccant pack, and reseal.

    3. Add Assay Diluent
    4.   For Serum & Plasma Samples: Add 100 µL of Assay Diluent to each well.
      For Cell Culture Supernate Samples: Add 50 µL Assay Diluent to each well.

    5. Add Standard, Control, or Sample
    6.   For Serum & Plasma Samples: Add 100 µL of Standard, control, or sample to each well. Cover with a plate sealer, and incubate at room temperature for 2 hours.
      For Cell Culture Supernate Samples: Add 200 µL of Standard, control, or sample to each well. Cover with a plate sealer, and incubate at room temperature for 2 hours.
    7.   Aspirate each well and wash, repeating the process twice for a total of 3 washes.

    8. 200 µL Conjugate
    9.   Add 200 µL of Conjugate to each well. Cover with a new plate sealer, and incubate at room temperature for 2 hours.
    10.   Aspirate and wash 3 times.

    11. 200 µL Substrate Solution
    12.   Add 200 µL Substrate Solution to each well.
    13.   For Serum & Plasma Samples: Incubate at room temperature for 25 minutes. PROTECT FROM LIGHT.
      For Cell Culture Supernate Samples: Incubate at room temperature for 20 minutes. PROTECT FROM LIGHT.

    14. 50 µL Stop Solution
    15. Add 50 µL of Stop Solution to each well. Read at 450 nm within 30 minutes. Set wavelength correction to 540 nm or 570 nm.
    Citations:

    R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

    Showing Results 1 - 10 of 282
    Filter your results:

    Species
    Sample Type
    1. Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma.
      Authors: Dobrzycka B, Mackowiak-Matejczyk B, Terlikowska K, Kulesza-Bronczyk B, Kinalski M, Terlikowski S
      Tumour Biol, 2015;0(0):4157.
      Species: Human
      Sample Type: Serum
    2. Obstructive sleep apnoea syndrome, endothelial function and markers of endothelialization. Changes after CPAP.
      Authors: Munoz-Hernandez R, Vallejo-Vaz A, Sanchez Armengol A, Moreno-Luna R, Caballero-Eraso C, Macher H, Villar J, Merino A, Castell J, Capote F, Stiefel P
      PLoS ONE, 2015;10(3):e0122091.
      Species: Human
      Sample Type: Serum
    3. The anti-angiogenic and cytotoxic effects of the boswellic acid analog BA145 are potentiated by autophagy inhibitors.
      Authors: Pathania A, Wani Z, Guru S, Kumar S, Bhushan S, Korkaya H, Seals D, Kumar A, Mondhe D, Ahmed Z, Chandan B, Malik F
      Mol Cancer, 2015;14(1):6.
      Species: Human
      Sample Type: Cell Culture Supernates
    4. MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma.
      Authors: Mohan S, Vander Broek R, Shah S, Eytan D, Pierce M, Carlson S, Coupar J, Zhang J, Cheng H, Chen Z, Van Waes C
      Clin Cancer Res, 2015;21(17):3946-56.
      Species: Human
      Sample Type: Cell Culture Supernates
    5. miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer.
      Authors: Xiong Y, Kotian S, Zeiger M, Zhang L, Kebebew E
      PLoS ONE, 2015;10(8):e0130496.
      Species: Human
      Sample Type: Cell Culture Supernates
    6. Rac1 Regulates Endometrial Secretory Function to Control Placental Development.
      Authors: Davila J, Laws M, Kannan A, Li Q, Taylor R, Bagchi M, Bagchi I
      PLoS Genet, 2015;11(8):e1005458.
      Species: Human
      Sample Type: Cell Culture Supernates
    7. STAT3 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin.
      Authors: Liao X, Wang N, Zhao D, Zheng D, Zheng L, Xing W, Ma W, Bao L, Dong J, Zhang T
      J Biol Chem, 2015;290(32):19641-52.
      Species: Human
      Sample Type: Cell Culture Supernates
    8. Inhibition of placental growth factor in renal cell carcinoma.
      Authors: Bessho H, Wong B, Huang D, Siew E, Huang D, Tan J, Ong C, Tan S, Matsumoto K, Iwamura M, Teh B
      Anticancer Res, 2015;35(1):531-41.
      Species: Human
      Sample Type: Cell Culture Supernates
    9. Tanshinone IIA inhibits HIF-1alpha and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway.
      Authors: Li G, Shan C, Liu L, Zhou T, Zhou J, Hu X, Chen Y, Cui H, Gao N
      PLoS ONE, 2015;10(2):e0117440.
      Species: Human
      Sample Type: Cell Culture Supernates
    10. In situ normoxia enhances survival and proliferation rate of human adipose tissue-derived stromal cells without increasing the risk of tumourigenesis.
      Authors: Choi, Jane Ru, Pingguan-Murphy, Belinda, Wan Abas, Wan Abu, Yong, Kar Wey, Poon, Chi Tat, Noor Azmi, Mat Aden, Omar, Siti Zaw, Chua, Kien Hui, Xu, Feng, Wan Safwani, Wan Kama
      PLoS ONE, 2015;10(1):e0115034.
      Species: Human
      Sample Type: Cell Culture Supernates
    11. Deleted in malignant brain tumors 1 (DMBT1) elicits increased VEGF and decreased IL-6 production in type II lung epithelial cells.
      Authors: Muller H, Nagel C, Weiss C, Mollenhauer J, Poeschl J
      BMC Pulm Med, 2015;15(0):32.
      Species: Human
      Sample Type: Tracheal Aspirates
    12. Selective Interference Targeting of Lnk in Umbilical Cord-Derived Late Endothelial Progenitor Cells Improves Vascular Repair, Following Hind Limb Ischemic Injury, via Regulation of JAK2/STAT3 Signaling.
      Authors: Lee, Sang Hun, Lee, Kyeung B, Lee, Jun Hee, Kang, Songhwa, Kim, Hwi Gon, Asahara, Takayuki, Kwon, Sang Mo
      Stem Cells, 2015;33(5):1490-500.
      Species: Human
      Sample Type: Cell Culture Supernates
    13. Identification of tumour-reactive lymphatic endothelial cells capable of inducing progression of gastric cancer.
      Authors: Tokumoto M, Tanaka H, Tauchi Y, Kasashima H, Kurata K, Yashiro M, Sakurai K, Toyokawa T, Kubo N, Amano R, Kimura K, Muguruma K, Maeda K, Ohira M, Hirakawa K
      Br J Cancer, 2015;113(7):1046-54.
      Species: Human
      Sample Type: Cell Culture Supernates
    14. Significant Correlation between Retinal Venous Tortuosity and Aqueous Vascular Endothelial Growth Factor Concentration in Eyes with Central Retinal Vein Occlusion.
      Authors: Yasuda S, Kachi S, Kondo M, Ueno S, Kaneko H, Terasaki H
      PLoS ONE, 2015;10(7):e0134267.
      Species: Human
      Sample Type: Aqueous humor
    15. Intertumor heterogeneity in vascularity and invasiveness of artificial melanoma brain metastases.
      Authors: Simonsen T, Gaustad J, Rofstad E
      J Exp Clin Cancer Res, 2015;34(0):150.
      Species: Human
      Sample Type: Cell Culture Supernates
    16. VEGF in patients with advanced hepatocellular carcinoma receiving intra-arterial chemotherapy.
      Authors: Matsui D, Nagai H, Mukozu T, Ogino Y, Sumino Y
      Anticancer Res, 2015;35(4):2205-10.
      Species: Human
      Sample Type: Serum
    17. The tyrosine phosphatase SHP-1 regulates hypoxia inducible factor-1alpha (HIF-1alpha) protein levels in endothelial cells under hypoxia.
      Authors: Alig S, Stampnik Y, Pircher J, Rotter R, Gaitzsch E, Ribeiro A, Wornle M, Krotz F, Mannell H
      PLoS ONE, 2015;10(3):e0121113.
      Species: Human
      Sample Type: Cell Culture Supernates
    18. Selecting bioactive phenolic compounds as potential agents to inhibit proliferation and VEGF expression in human ovarian cancer cells.
      Authors: He Z, Li B, Rankin G, Rojanasakul Y, Chen Y
      Oncol Lett, 2015;9(3):1444-1450.
    19. Gain of HIF-1alpha under normoxia in cancer mediates immune adaptation through the AKT/ERK and VEGFA axes.
      Authors: Lee Y, Bae H, Noh K, Song K, Ye S, Mao C, Lee K, Wu T, Kim T
      Clin Cancer Res, 2015;21(6):1438-46.
    20. Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring response to adjuvant radiochemotherapy in patients with primary cervical cancer--results of a companion protocol of the randomized NOGGO-AGO phase III clinical trial.
      Authors: Braicu E, Gasimli K, Richter R, Nassir M, Kummel S, Blohmer J, Yalcinkaya I, Chekerov R, Ignat I, Ionescu A, Mentze M, Fotopoulou C, Pop C, Lichtenegger W, Sehouli J
      Anticancer Res, 2014;34(1):385-91.
      Species: Human
      Sample Type: Serum
    21. Effects of a single intravitreal injection of aflibercept and ranibizumab on glomeruli of monkeys.
      Authors: Tschulakow A, Christner S, Julien S, Ludinsky M, van der Giet M, Schraermeyer U
      PLoS ONE, 2014;9(11):e113701.
      Species: Primate - macaca fascicularis
      Sample Type: Plasma
    22. Sunitinib suppress neuroblastoma growth through degradation of MYCN and inhibition of angiogenesis.
      Authors: Calero R, Morchon E, Johnsen J, Serrano R
      PLoS ONE, 2014;9(4):e95628.
      Species: Human
      Sample Type: Cell Culture Supernates
    23. Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination.
      Authors: Zhan Z, Xie X, Cao H, Zhou X, Zhang X, Fan H, Liu Z
      Autophagy, 2014;10(2):257-68.
      Species: Human
      Sample Type: Cell Culture Supernates
    24. Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K/Akt enhanced beta-catenin/Tcf-Lef dependent transcription.
      Authors: Fernandez J, Rodriguez D, Valenzuela M, Calderon C, Urzua U, Munroe D, Rosas C, Lemus D, Diaz N, Wright M, Leyton L, Tapia J, Quest A
      Mol Cancer, 2014;13(0):209.
      Species: Human
      Sample Type: Cell Culture Supernates
    25. Heat shock protein 27 attenuates neointima formation and accelerates reendothelialization after arterial injury and stent implantation: importance of vascular endothelial growth factor up-regulation.
      Authors: Ma X, Hibbert B, McNulty M, Hu T, Zhao X, Ramirez F, Simard T, de Belleroche J, O'Brien E
      FASEB J, 2014;28(2):594-602.
      Species: Human
      Sample Type: Cell Culture Supernates
    26. Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1alpha/p300 complex in a preclinical model of prostate cancer.
      Authors: Reece K, Richardson E, Cook K, Campbell T, Pisle S, Holly A, Venzon D, Liewehr D, Chau C, Price D, Figg W
      Mol Cancer, 2014;13(0):91.
      Species: Human
      Sample Type: Cell Culture Supernates
    27. DeltaNp63 promotes pediatric neuroblastoma and osteosarcoma by regulating tumor angiogenesis.
      Authors: Bid, Hemant K, Roberts, Ryan D, Cam, Maren, Cam M, Audino A, Audino, Anthony, Kurmasheva, Raushan, Lin, Jiayuh, Houghton, Peter J, Cam, Hakan, Cam H
      Cancer Res, 2014;74(1):320-9.
      Species: Human
      Sample Type: Cell Culture Supernates
    28. Gene electro transfer of plasmid encoding vascular endothelial growth factor for enhanced expression and perfusion in the ischemic swine heart.
      Authors: Hargrave, Barbara, Strange, Robert J, Navare, Sagar, Stratton, Michael, Burcus, Nina, Murray, Len, Lundberg, Cathryn, Bulysheva, Anna, Li, Fanying, Heller, Richard
      PLoS ONE, 2014;9(12):e115235.
      Species: Human
      Sample Type: Tissue Homogenates
    29. Cbx4 governs HIF-1alpha to potentiate angiogenesis of hepatocellular carcinoma by its SUMO E3 ligase activity.
      Authors: Li J, Xu Y, Long X, Wang W, Jiao H, Mei Z, Yin Q, Ma L, Zhou A, Wang L, Yao M, Xia Q, Chen G
      Cancer Cell, 2014;25(1):118-31.
      Species: Human
      Sample Type: Cell Culture Supernates
    30. Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognostic accuracy.
      Authors: Necchi A, Pennati M, Zaffaroni N, Landoni E, Giannatempo P, Raggi D, Schwartz L, Morosi C, Crippa F, Fare E, Nicolai N, Lanocita R, Sava T, Sacco C, Messina C, Ortega C, De Braud F, Salvioni R, Daidone M, Gianni A, Mariani L
      Br J Cancer, 2014;110(1):26-33.
      Species: Human
      Sample Type: Plasma
    31. RUNX3 inhibits hypoxia-inducible factor-1alpha protein stability by interacting with prolyl hydroxylases in gastric cancer cells.
      Authors: Lee S, Bae S, Kim K, Lee Y
      Oncogene, 2014;33(11):1458-67.
      Species: Human
      Sample Type: Whole Cells
    32. O-GlcNAc modification of transcription factor Sp1 mediates hyperglycemia-induced VEGF-A upregulation in retinal cells.
      Authors: Donovan K, Alekseev O, Qi X, Cho W, Azizkhan-Clifford J
      Invest Ophthalmol Vis Sci, 2014;55(12):7862-73.
      Species: Human
      Sample Type: Cell Culture Supernates
    33. Interferon-beta inhibits glioma angiogenesis through downregulation of vascular endothelial growth factor and upregulation of interferon inducible protein 10.
      Authors: Takano S, Ishikawa E, Matsuda M, Yamamoto T, Matsumura A
      Int J Oncol, 2014;45(5):1837-46.
      Species: Human
      Sample Type: cell supernates
    34. Systemic upregulation of PDGF-B in patients with neovascular AMD.
      Authors: Zehetner C, Kirchmair R, Neururer S, Kralinger M, Bechrakis N, Kieselbach G
      Invest Ophthalmol Vis Sci, 2014;55(1):337-44.
      Species: Human
      Sample Type: Plasma
    35. Effects of sFlt-1 and alpha 2-macroglobulin on vascular endothelial growth factor-induced endothelin-1 upregulation in human microvascular endothelial cells.
      Authors: Yi K, Jung S, Cho G, Seol H, Hong S, Oh M, Kim H
      Placenta, 2014;35(1):64-9.
      Species: Human
      Sample Type: Cell Culture Supernates
    36. alpha6-Integrin is required for the adhesion and vasculogenic potential of hemangioma stem cells.
      Authors: Smadja D, Guerin C, Boscolo E, Bieche I, Mulliken J, Bischoff J
      Stem Cells, 2014;32(3):684-93.
      Species: Human
      Sample Type: Cell Culture Supernates
    37. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
      Authors: Ekstrom E, Bergenfelz C, von Bulow V, Serifler F, Carlemalm E, Jonsson G, Andersson T, Leandersson K
      Mol Cancer, 2014;13(0):88.
      Species: Human
      Sample Type: cell culture supernate
    38. Osteosarcoma cells promote the production of pro-tumor cytokines in mesenchymal stem cells by inhibiting their osteogenic differentiation through the TGF-beta/Smad2/3 pathway.
      Authors: Tu B, Peng Z, Fan Q, DU L, Yan W, Tang T
      Exp Cell Res, 2014;320(1):164-73.
      Species: Human
      Sample Type: cell culture supernate
    39. Evaluation of a new recombinant oncolytic vaccinia virus strain GLV-5b451 for feline mammary carcinoma therapy.
      Authors: Adelfinger M, Gentschev I, Grimm de Guibert J, Weibel S, Langbein-Laugwitz J, Hartl B, Murua Escobar H, Nolte I, Chen N, Aguilar R, Yu Y, Zhang Q, Frentzen A, Szalay A
      PLoS ONE, 2014;9(8):e104337.
      Species: Feline
      Sample Type: Cell Culture Supernates
    40. Peroxisome proliferator-activated receptor gamma ligands inhibit VEGF-mediated vasculogenic mimicry of prostate cancer through the AKT signaling pathway.
      Authors: Qin L, Ren Y, Chen A, Guo F, Xu F, Gong C, Cheng P, Du Y, Liao H
      Mol Med Rep, 2014;10(1):276-82.
      Species: Human
      Sample Type: Cell Culture Supernates
    41. Mobilization of circulating endothelial progenitor cells correlates with the clinical course of hantavirus disease.
      Authors: Krautkramer E, Grouls S, Hettwer D, Rafat N, Tonshoff B, Zeier M
      J Virol, 2014;88(1):483-9.
      Species: Human
      Sample Type: Plasma
    42. COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro.
      Authors: Du Y, Shi A, Han B, Li S, Wu D, Jia H, Zheng C, Ren L, Fan Z
      Int J Oncol, 2014;44(4):1385-93.
      Species: Human
      Sample Type: Cell Culture Supernates
    43. Metabolic impact of anti-angiogenic agents on U87 glioma cells.
      Authors: Mesti T, Savarin P, Triba M, Le Moyec L, Ocvirk J, Banissi C, Carpentier A
      PLoS ONE, 2014;9(6):e99198.
      Species: Human
      Sample Type: cell culture supernate
    44. Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy.
      Authors: Jurgensmeier J, Schmoll H, Robertson J, Brooks L, Taboada M, Morgan S, Wilson D, Hoff P
      Br J Cancer, 2013;108(6):1316-23.
      Species: Human
      Sample Type: Plasma
    45. The mechanism through which octreotide inhibits hepatic stellate cell activity.
      Authors: Wang J, Wang L, Song G, Han B
      Mol Med Rep, 2013;7(5):1559-64.
      Species: Human
      Sample Type: Cell Culture Supernates
    46. Caspase 3 involves in neuroplasticity, microglial activation and neurogenesis in the mice hippocampus after intracerebral injection of kainic acid.
      Authors: Tzeng, Tsai-Ten, Tsay, Huey-Jen, Chang, Luping, Hsu, Chia-Lin, Lai, Tzu-Hsua, Huang, Fong-Lee, Shiao, Young-Ji
      J Biomed Sci, 2013;20(0):90.
      Species: Human
      Sample Type: Cell Culture Supernates
    47. A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis.
      Authors: Abuhusain, Hazem J, Matin, Azadeh, Qiao, Qiao, Shen, Han, Kain, Nupur, Day, Bryan W, Stringer, Brett W, Daniels, Benjamin, Laaksonen, Maarit A, Teo, Charlie, McDonald, Kerrie L, Don, Anthony
      J Biol Chem, 2013;288(52):37355-64.
      Species: Human
      Sample Type: Cell Culture Supernates
    48. Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer.
      Authors: Armstrong A, Haggman M, Stadler W, Gingrich J, Assikis V, Polikoff J, Damber J, Belkoff L, Nordle O, Forsberg G, Carducci M, Pili R
      Clin Cancer Res, 2013;19(24):6891-901.
      Species: Human
      Sample Type: Plasma
    49. The role of SDF-1-CXCR4/CXCR7 axis in biological behaviors of adipose tissue-derived mesenchymal stem cells in vitro.
      Authors: Li Q, Zhang A, Tao C, Li X, Jin P
      Biochem Biophys Res Commun, 2013;441(3):675-80.
      Species: Human
      Sample Type: Cell Culture Supernates
    50. Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.
      Authors: Briasoulis, Evangelo, Aravantinos, Gerasimo, Kouvatseas, George, Pappas, Periklis, Biziota, Eirini, Sainis, Ioannis, Makatsoris, Thomas, Varthalitis, Ioannis, Xanthakis, Ioannis, Vassias, Antonios, Klouvas, George, Boukovinas, Ioannis, Fountzilas, George, Syrigos, Kostanti, Kalofonos, Haralamb, Samantas, Epaminon
      BMC Cancer, 2013;13(1):263.
      Species: Human
      Sample Type: Plasma
    51. Transcriptional repression of VEGF by ZNF24: mechanistic studies and vascular consequences in vivo.
      Authors: Jia, Di, Hasso, Sean M, Chan, Joanne, Filingeri, Domenic, D'Amore, Patricia, Rice, Lori, Pampo, Christin, Siemann, Dietmar, Zurakowski, David, Rodig, Scott J, Moses, Marsha A
      Blood, 2013;121(4):707-15.
      Species: Human
      Sample Type: Cell Culture Supernates
    52. The contributions of HIF-target genes to tumor growth in RCC.
      Authors: Zhang, Ting, Niu, Xiaohua, Liao, Lili, Cho, Eun-Ah, Yang, Haifeng
      PLoS ONE, 2013;8(11):e80544.
      Species: Human
      Sample Type: Cell Lysate
    53. Inhibition of STAT3 reduces astrocytoma cell invasion and constitutive activation of STAT3 predicts poor prognosis in human astrocytoma.
      Authors: Liang, Qinchuan, Ma, Chenkai, Zhao, Yang, Gao, Guodong, Ma, Jie
      PLoS ONE, 2013;8(12):e84723.
      Species: Human
      Sample Type: Cell Culture Supernates
    54. Clinical outcome, proteome kinetics and angiogenic factors in serum after thermoablation of colorectal liver metastases.
      Authors: Wertenbroek, Marieke, Schepers, Marianne, Kamminga-Rasker, Hannetta, Bottema, Jan T, Muller Kobold, Anneke C, Roelofsen, Han, de Jong, Koert P
      BMC Cancer, 2013;13(1):266.
      Species: Human
      Sample Type: Serum
    55. Designing nanotopographical density of extracellular matrix for controlled morphology and function of human mesenchymal stem cells.
      Authors: Kim J, Kim H, Lim K, Kim Y, Seonwoo H, Park S, Lim H, Kim D, Suh K, Choung P, Choung Y, Chung J
      Sci Rep, 2013;3(0):3552.
      Species: Human
      Sample Type: Cell Culture Supernates
    56. Effect of platelet lysate on human cells involved in different phases of wound healing.
      Authors: Barsotti M, Losi P, Briganti E, Sanguinetti E, Magera A, Al Kayal T, Feriani R, Di Stefano R, Soldani G
      PLoS ONE, 2013;8(12):e84753.
      Species: Human
      Sample Type: Cell Lysate
    57. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.
      Authors: Patten IS, Rana S, Shahul S, Rowe GC, Jang C, Liu L, Hacker MR, Rhee JS, Mitchell J, Mahmood F, Hess P, Farrell C, Koulisis N, Khankin EV, Burke SD, Tudorache I, Bauersachs J, del Monte F, Hilfiker-Kleiner D, Karumanchi SA, Arany Z
      Nature, 2012;485(7398):333-8.
      Species: Human
      Sample Type: Plasma
    58. Serum neurotensin (NT) is increased in psoriasis and NT induces vascular endothelial growth factor release from human mast cells.
      Authors: Vasiadi M, Therianou A, Alysandratos KD, Katsarou-Katsari A, Petrakopoulou T, Theoharides A, Papadavid E, Stavrianeas N, Antoniou C, Kalogeromitros D, Theoharides TC
      Br. J. Dermatol., 2012;166(6):1349-52.
      Species: Human
      Sample Type: Cell Culture Supernates
    59. Biomarkers for antitumor activity of bevacizumab in gastric cancer models.
      Authors: Yamashita-Kashima Y, Fujimoto-Ouchi K, Yorozu K, Kurasawa M, Yanagisawa M, Yasuno H, Mori K
      BMC Cancer, 2012;12(0):37.
      Species: Human
      Sample Type: Tissue Homogenates
    60. A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium report.
      Authors: Widemann B, Kim A, Fox E, Baruchel S, Adamson P, Ingle A, Glade Bender J, Burke M, Weigel B, Stempak D, Balis F, Blaney S
      Clin Cancer Res, 2012;18(21):6011-22.
      Species: Human
      Sample Type: Plasma
    61. Comparison of the levels of the growth factors in umbilical cord serum and human milk and its clinical significance.
      Authors: Patki S, Patki U, Patil R, Indumathi S, Kaingade P, Bulbule A, Nikam A, Pishte A
      Cytokine, 2012;59(2):305-8.
      Species: Human
      Sample Type: umbilical cord serum
    62. Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer.
      Clin. Cancer Res., 2012;18(12):3428-39.
      Species: Human
      Sample Type: Plasma
    63. XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis.
      BMC Cancer, 2012;12(0):271.
      Species: Human
      Sample Type: Plasma
    64. Late SV40 factor (LSF) enhances angiogenesis by transcriptionally up-regulating matrix metalloproteinase-9 (MMP-9).
      Authors: Santhekadur PK, Gredler R, Chen D
      J. Biol. Chem., 2012;287(5):3425-32.
      Species: Human
      Sample Type: Cell Culture Supernates
    65. Semaphorin 4A exerts a proangiogenic effect by enhancing vascular endothelial growth factor-A expression in macrophages.
      Authors: Meda C, Molla F, De Pizzol M
      J. Immunol., 2012;188(8):4081-92.
      Species: Human
      Sample Type: Cell Culture Supernates
    66. Met Receptor Tyrosine Kinase Signaling Induces Secretion of the Angiogenic Chemokine Interleukin-8/CXCL8 in Pancreatic Cancer.
      Authors: Hill KS, Gaziova I, Harrigal L
      PLoS ONE, 2012;7(7):e40420.
      Species: Human
      Sample Type: Cell Culture Supernates
    67. Bevacizumab attenuates major signaling cascades and eIF4E translation initiation factor in multiple myeloma cells.
      Authors: Attar-Schneider O, Drucker L, Zismanov V
      Lab. Invest., 2012;92(2):178-90.
      Species: Human
      Sample Type: Cell Culture Supernates
    68. Neurotensin and CRH interactions augment human mast cell activation.
      Authors: Alysandratos K, Asadi S, Angelidou A, Zhang B, Sismanopoulos N, Yang H, Critchfield A, Theoharides T
      PLoS ONE, 2012;7(11):e48934.
      Species: Human
      Sample Type: Cell Culture Supernates
    69. Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma.
      Authors: Llovet JM, Pena CE, Lathia CD, Shan M, Meinhardt G, Bruix J, Pallota MG, Zarba JJ, Boyer M, Riordan S, Strickland A, Tebbutt N, Thomson B, Borbath I, De Greve J, Van Laethem J-, Van Steenbergen W, Van Vlierberghe H, Barrios C, Cosme de Oliveira A, Kotzev I, Takov D, Tchernev K, Burak K, Ma M, Metrakos P, Olweny C, Sherman M, Gamargo Garate C, Martinez-Castillo J, Beaugrand M, Bennouna J, Blanc J-, Bronowicki J-, Degos F, Dominguez S, Grange J-, Hillon P, Raoul J-, Seitz J-, Blum H, Buggisch P, Caspary W, Dollinger M, Gerken G, Goke B, Gregor M, Greten T, Haussinger D, Hilgard P, Scherübl J, Scheulen M, Schmid R, Spengler U, Wiest R, Zeuzem S, Arvanitakis C, Germanidis G, Katsos I, Figer A, Stemmer S, Amadori D, Bolondi L, Cognetti F, Craxi A, Farinati F, Gridelli C, Martoni A, Mazzaferro V, Porta C, Ricci S, Sangiovanni A, Santoro A, Trevisani F, Cisnero Garza LE, Gane E, O'Donnell A, Leon J, Lozano A, Jassem J, Rydzewska G, Szawlowski A, Tomczak P, Badulescu F, Miron L, Kubyshkin V, Bruix J, Forner A, Bustamante Schneider J, Diago M, Montero Alvarez JL, Pascual S, Ruíz del Arbol L, Sangro B, Solá R, Tabernero J, Muellhaupt B, Roth A, Jeffry Evans TR, Falk S, Meyer T, Reeves H, Ross P, Befeler A, Boyer T, Britten C, Byrne T, Garcia-Tsao G, Gold P, Goldenberg A, Heuman D, Kennedy P, Koch A, Llovet JM, Marrero J, Schilsky M, Schwartz J, Schwartz M
      Clin. Cancer Res., 2012;18(8):2290-300.
      Species: Human
      Sample Type: Plasma
    70. Hypoxia potentiates glioma-mediated immunosuppression.
      Authors: Wei J, Wu A, Kong LY, Wang Y, Fuller G, Fokt I, Melillo G, Priebe W, Heimberger AB
      PLoS ONE, 2012;6(1):e16195.
      Species: Human
      Sample Type: Cell Culture Supernates
    71. Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.
      Clin. Cancer Res., 2012;18(18):5031-42.
      Species: Human
      Sample Type: Plasma
    72. Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma.
      Authors: Dupuy S, Lambert M, Zucman D, Choukem SP, Tognarelli S, Pages C, Lebbe C, Caillat-Zucman S
      PLoS Pathog., 2012;8(1):e1002486.
      Species: Human
      Sample Type: Cell Culture Supernates
    73. Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in Amyotrophic Lateral Sclerosis (ALS) patients.
      Authors: Gupta PK, Prabhakar S
      J Neuroinflammation, 2011;8(1):47.
      Species: Human
      Sample Type: Serum
    74. Thrombospondin-1 triggers cell migration and development of advanced prostate tumors.
      Authors: Firlej V, Mathieu JR, Gilbert C, Lemonnier L, Nakhle J, Gallou-Kabani C, Guarmit B, Morin A, Prevarskaya N, Delongchamps NB, Cabon F
      Cancer Res., 2011;71(24):7649-58.
      Species: Human
      Sample Type: Cell Lysates
    75. Expansion of human cardiac stem cells in physiological oxygen improves cell production efficiency and potency for myocardial repair.
      Authors: Li TS, Cheng K, Malliaras K, Matsushita N, Sun B, Marban L, Zhang Y, Marban E
      Cardiovasc. Res., 2011;89(1):157-65.
      Species: Human
      Sample Type: Cell Culture Supernates
    76. Leptin administered in physiological or pharmacological doses does not regulate circulating angiogenesis factors in humans.
      Authors: Aronis KN, Diakopoulos KN, Fiorenza CG
      Diabetologia, 2011;54(9):2358-67.
      Species: Human
      Sample Type: Serum
    77. Inflammation associated with obesity: relationship with blood and bone marrow endothelial cells.
      Authors: McGuire TR, Brusnahan SK, Bilek LD, Jackson JD, Kessinger MA, Berger AM, Garvin KL, O'Kane BJ, Tuljapurkar SR, Sharp JG
      Obesity (Silver Spring), 2011;19(11):2130-6.
      Species: Human
      Sample Type: Plasma
    78. Macrophage infiltration predicts a poor prognosis for human ewing sarcoma.
      Authors: Fujiwara T, Fukushi J, Yamamoto S, Matsumoto Y, Setsu N, Oda Y, Yamada H, Okada S, Watari K, Ono M, Kuwano M, Kamura S, Iida K, Okada Y, Koga M, Iwamoto Y
      Am. J. Pathol., 2011;179(3):1157-70.
      Species: Human
      Sample Type: Cell Culture Supernates
    79. Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer.
      Authors: Volkova E, Willis JA, Wells JE, Robinson BA, Dachs GU, Currie MJ
      Br. J. Cancer, 2011;104(1):51-9.
      Species: Human
      Sample Type: Serum
    80. Alternatives to the use of fetal bovine serum: human platelet lysates as a serum substitute in cell culture media.
      Authors: Rauch C, Feifel E, Amann EM, Spotl HP, Schennach H, Pfaller W, Gstraunthaler G
      ALTEX, 2011;28(4):305-16.
      Species: Human
      Sample Type: Cell Lysates
    81. Serum levels of beta-catenin as a potential marker for genotype 4/hepatitis C-associated hepatocellular carcinoma.
      Authors: Zekri A, Bahnassy A, Alam El-Din H, Morsy H, Shaarawy S, Moharram N, Daoud S
      Oncol Rep, 2011;26(4):825-31.
      Species: Human
      Sample Type: Serum
    82. Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities.
      Authors: Farha S, Asosingh K, Xu W, Sharp J, George D, Comhair S, Park M, Tang WH, Loyd JE, Theil K, Tubbs R, Hsi E, Lichtin A, Erzurum SC
      Blood, 2011;117(13):3485-93.
      Species: Human
      Sample Type: Plasma
    83. Pertuzumab in combination with trastuzumab shows significantly enhanced antitumor activity in HER2-positive human gastric cancer xenograft models.
      Authors: Yamashita-Kashima Y, Iijima S, Yorozu K, Furugaki K, Kurasawa M, Ohta M, Fujimoto-Ouchi K
      Clin. Cancer Res., 2011;17(15):5060-70.
      Species: Human
      Sample Type: Tissue Homogenates
    84. Endocrine gland-derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome in women undergoing controlled ovarian hyperstimulation.
      Authors: Gao MZ, Zhao XM, Sun ZG
      Fertil. Steril., 2011;95(2):673-8.
      Species: Human
      Sample Type: Serum
    85. Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer.
      Authors: Loupakis F, Cremolini C, Fioravanti A
      Br. J. Cancer, 2011;104(8):1262-9.
      Species: Human
      Sample Type: Plasma
    86. In vitro vascular tube formation testing as a tool for treatment individualisation in patients with cervical cancer.
      Authors: Landt S, Heidecke H, Korlach S, Reuter C, Schwidde I, Barinoff J, Thill M, Sehouli J, Kummel S
      Anticancer Res., 2011;31(8):2609-15.
      Species: Human
      Sample Type: Serum
    87. Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept.
      Authors: de Groot JF, Piao Y, Tran H, Gilbert M, Wu HK, Liu J, Bekele BN, Cloughesy T, Mehta M, Robins HI, Lassman A, Deangelis L, Camphausen K, Chen A, Yung W, Prados M, Wen PY, Heymach JV
      Clin. Cancer Res., 2011;17(14):4872-4881.
      Species: Human
      Sample Type: Plasma
    88. Prognostic significance of angiogenic factors in uterine cervical cancer.
      Authors: Landt S, Wehling M, Heidecke H, Jeschke S, Korlach S, Stoblen F, Schmid P, Blohmer JU, Lichtenegger W, Sehouli J, Kummel S
      Anticancer Res., 2011;31(8):2589-95.
      Species: Human
      Sample Type: Serum
    89. Stromal interaction essential for vascular endothelial growth factor A-induced tumour growth via transforming growth factor-beta signalling.
      Authors: Weidenaar AC, Ter Elst A, Kampen KR, Meeuwsen-de Boer TG, de Jonge HJ, Scherpen FJ, den Dunnen WF, Kamps WA, de Bont ES
      Br. J. Cancer, 2011;105(12):1856-63.
      Species: Human
      Sample Type: Cell Culture Supernates
    90. Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors.
      Authors: Farace F, Gross-Goupil M, Tournay E, Taylor M, Vimond N, Jacques N, Billiot F, Mauguen A, Hill C, Escudier B
      Br. J. Cancer, 2011;104(7):1144-50.
      Species: Human
      Sample Type: Plasma
    91. Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study.
      Authors: Dubois SG, Shusterman S, Ingle AM, Ahern CH, Reid JM, Wu B, Baruchel S, Glade-Bender J, Ivy P, Grier HE, Adamson PC, Blaney SM
      Clin. Cancer Res., 2011;17(15):5113-22.
      Species: Human
      Sample Type: Plasma
    92. Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib.
      Authors: Harmon CS, DePrimo SE, Raymond E, Cheng AL, Boucher E, Douillard JY, Lim HY, Kim JS, Lechuga MJ, Lanzalone S, Lin X, Faivre S
      J Transl Med, 2011;9(0):120.
      Species: Human
      Sample Type: Plasma
    93. CD34+ progenitor cells likely are involved in the good functional recovery after intracerebral hemorrhage in humans.
      Authors: Sobrino T, Arias S, Perez-Mato M, Agulla J, Brea D, Rodriguez-Yanez M, Castillo J
      J. Neurosci. Res., 2011;89(7):979-85.
      Species: Human
      Sample Type: Serum
    94. Synergistic effects of imatinib and carboplatin on VEGF, PDGF and PDGF-Ralpha/beta expression in squamous cell carcinoma of the head and neck in vitro.
      Authors: Schultz JD, Rotunno S, Riedel F, Anders C, Erben P, Hofheinz RD, Faber A, Thorn C, Sommer JU, Hormann K, Sauter A
      Int. J. Oncol., 2011;38(4):1001-12.
      Species: Human
      Sample Type: Cell Lysates
    95. Signs of reduced angiogenic activity after surgical removal of deeply infiltrating endometriosis.
      Authors: Bourlev V, Iljasova N, Adamyan L, Larsson A, Olovsson M
      Fertil. Steril., 2010;94(1):52-7.
      Species: Human
      Sample Type: Serum
    96. VEGF-A promotes lymphoma tumour growth by activation of STAT proteins and inhibition of p27(KIP1) via paracrine mechanisms.
      Authors: Roorda BD, Ter Elst A, Scherpen FJ, Meeuwsen-de Boer TG, Kamps WA, de Bont ES
      Eur. J. Cancer, 2010;46(5):974-82.
      Species: Human
      Sample Type: Plasma
    97. Dissecting the effects of lipopolysaccharides from nonlipopolysaccharide molecules in experimental porcine meningococcal sepsis.
      Authors: Hellerud BC, Nielsen EW, Thorgersen EB, Lindstad JK, Pharo A, Tonnessen TI, Castellheim A, Mollnes TE, Brandtzaeg P
      Crit. Care Med., 2010;38(6):1467-74.
      Species: Porcine
      Sample Type: Plasma
    98. The change of cytokines in tear and blood after different pterygium operation.
      Authors: Lee JK, Song YS, Shin JS, Kwon YS, Shin MS, Kim JC
      Cytokine, 2010;49(2):148-54.
      Species: Human
      Sample Type: Tears
    99. Inhibition of EGFR pathway signaling and the metastatic potential of breast cancer cells by PA-MSHA mediated by type 1 fimbriae via a mannose-dependent manner.
      Authors: Liu ZB, Hou YF, Zhu J
      Oncogene, 2010;29(20):2996-3009.
      Species: Human
      Sample Type: Cell Culture Supernates
    100. Vitreous VEGF clearance is increased after vitrectomy.
      Authors: Lee SS, Ghosn C, Yu Z, Zacharias LC, Kao H, Lanni C, Abdelfattah N, Kuppermann B, Csaky KG, D'Argenio DZ, Burke JA, Hughes PM, Robinson MR
      Invest. Ophthalmol. Vis. Sci., 2010;51(4):2135-8.
      Species: Rabbit
      Sample Type: Vitreous Humor
    101. Vascular endothelial growth factor as an autocrine survival factor for retinal pigment epithelial cells under oxidative stress via the VEGF-R2/PI3K/Akt.
      Authors: Byeon SH, Lee SC, Choi SH, Lee HK, Lee JH, Chu YK, Kwon OW
      Invest. Ophthalmol. Vis. Sci., 2010;51(2):1190-7.
      Species: Human
      Sample Type: Cell Culture Supernates
    102. Defective angiogenesis in hypoplastic human fetal lungs correlates with nitric oxide synthase deficiency that occurs despite enhanced angiopoietin-2 and VEGF.
      Authors: Boucherat O, Franco-Montoya ML, Delacourt C, Martinovic J, Masse V, Elie C, Thebaud B, Benachi A, Bourbon JR
      Am. J. Physiol. Lung Cell Mol. Physiol., 2010;298(6):L849-56.
      Species: Human
      Sample Type: Tissue Homogenates
    103. Stromal cell-derived factor-1 is essential for photoreceptor cell protection in retinal detachment.
      Authors: Otsuka H, Arimura N, Sonoda S
      Am. J. Pathol., 2010;177(5):2268-77.
      Species: Human
      Sample Type: Vitreous Humor
    104. Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors.
      Authors: Nilsson MB, Zage PE, Zeng L, Xu L, Cascone T, Wu HK, Saigal B, Zweidler-McKay PA, Heymach JV
      Oncogene, 2010;29(20):2938-49.
      Species: Human
      Sample Type: Cell Culture Supernates
    105. The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo.
      Authors: Merdzhanova G, Gout S, Keramidas M, Edmond V, Coll JL, Brambilla C, Brambilla E, Gazzeri S, Eymin B
      Oncogene, 2010;29(39):5392-403.
      Species: Human
      Sample Type: Cell Culture Supernates
    106. Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia.
      Authors: Maffei R, Martinelli S, Santachiara R
      Blood, 2010;116(4):584-92.
      Species: Human
      Sample Type: Plasma
    107. Sensitive plasma protein analysis by microparticle-based proximity ligation assays.
      Authors: Darmanis S, Nong RY, Hammond M, Gu J, Alderborn A, Vanelid J, Siegbahn A, Gustafsdottir S, Ericsson O, Landegren U, Kamali-Moghaddam M
      Mol. Cell Proteomics, 2010;9(2):327-35.
      Species: Human
      Sample Type: Plasma
    108. Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation.
      Authors: Zhang H, Fagan DH, Zeng X
      Oncogene, 2010;29(17):2517-27.
      Species: Human
      Sample Type: Cell Culture Supernates
    109. Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor.
      Authors: Idriss NK, Lip GY, Balakrishnan B
      Thromb. Haemost., 2010;104(5):1029-37.
      Species: Human
      Sample Type: Plasma
    110. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model.
      Authors: Brave SR, Eberlein C, Shibuya M, Wedge SR, Barry ST
      Angiogenesis, 2010;13(4):337-47.
      Species: Human
      Sample Type: Cell Culture Supernates
    111. Human pregnancy specific beta-1-glycoprotein 1 (PSG1) has a potential role in placental vascular morphogenesis.
      Authors: Ha CT, Wu JA, Irmak S, Lisboa FA, Dizon AM, Warren JW, Ergun S, Dveksler GS
      Biol. Reprod., 2010;83(1):27-35.
      Species: Human
      Sample Type: Cell Culture Supernates
    112. Differential effect of ischaemic preconditioning on mobilisation and recruitment of haematopoietic and mesenchymal stem cells in porcine myocardial ischaemia-reperfusion.
      Authors: Gyongyosi M, Posa A, Pavo N, Hemetsberger R, Kvakan H, Steiner-Boker S, Petrasi Z, Manczur F, Pavo IJ, Edes IF, Wojta J, Glogar D, Huber K
      Thromb. Haemost., 2010;104(2):376-84.
      Species: Human
      Sample Type: Plasma
    113. Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice.
      Authors: Kosugi T, Nakayama T, Li Q, Chiodo VA, Zhang L, Campbell-Thompson M, Grant M, Croker BP, Nakagawa T
      Am. J. Physiol. Renal Physiol., 2010;298(3):F609-16.
      Species: Human
      Sample Type: Serum
    114. Cationic liposome coupled endostatin gene for treatment of peritoneal colon cancer.
      Authors: Lan KL, Ou-Yang F, Yen SH, Shih HL, Lan KH
      Clin. Exp. Metastasis, 2010;27(5):307-18.
      Species: Human
      Sample Type: Ascites
    115. Extended ischemia prevents HIF1alpha degradation at reoxygenation by impairing prolyl-hydroxylation: role of Krebs cycle metabolites.
      Authors: Serra-Perez A, Planas AM, Núñez-O'Mara A, Berra E, Garcia-Villoria J, Ribes A, Santalucia T
      J. Biol. Chem., 2010;285(24):18217-24.
      Species: Human
      Sample Type: Cell Culture Supernates
    116. Macrophage inhibitory cytokine-1 regulates melanoma vascular development.
      Authors: Huh SJ, Chung CY, Sharma A
      Am. J. Pathol., 2010;176(6):2948-57.
      Species: Human
      Sample Type: Serum
    117. Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch.
      Authors: Ding W, Knox TR, Tschumper RC
      Blood, 2010;116(16):2984-93.
      Species: Human
      Sample Type: Platelet-Poor Plasma
    118. Phase 1/2 study of preoperative docetaxel and mitoxantrone for high-risk prostate cancer.
      Authors: Garzotto M, Higano CS, O'Brien C, Rademacher BL, Janeba N, Fazli L, Lange PH, Lieberman S, Beer TM
      Cancer, 2010;116(7):1699-708.
      Species: Human
      Sample Type: Plasma
    119. Effect of intensive lifestyle changes on endothelial function and on inflammatory markers of atherosclerosis.
      Authors: Dod HS, Bhardwaj R, Sajja V, Weidner G, Hobbs GR, Konat GW, Manivannan S, Gharib W, Warden BE, Nanda NC, Beto RJ, Ornish D, Jain AC
      Am. J. Cardiol., 2010;105(3):362-7.
      Species: Human
      Sample Type: Serum
    120. Distraction osteogenesis induces endothelial progenitor cell mobilization without inflammatory response in man.
      Authors: Lee DY, Cho TJ, Lee HR, Park MS, Yoo WJ, Chung CY, Choi IH
      Bone, 2010;46(3):673-9.
      Species: Human
      Sample Type: Plasma
    121. A phase I trial of bortezomib with temozolomide in patients with advanced melanoma: toxicities, antitumor effects, and modulation of therapeutic targets.
      Authors: Su Y, Amiri KI, Horton LW
      Clin. Cancer Res., 2010;16(1):348-57.
      Species: Human
      Sample Type: Serum
    122. CD14 inhibition efficiently attenuates early inflammatory and hemostatic responses in Escherichia coli sepsis in pigs.
      Authors: Thorgersen EB, Hellerud BC, Nielsen EW, Barratt-Due A, Fure H, Lindstad JK, Pharo A, Fosse E, Tonnessen TI, Johansen HT, Castellheim A, Mollnes TE
      FASEB J., 2010;24(3):712-22.
      Species: Porcine
      Sample Type: Plasma
    123. VEGF-mediated angiogenesis stimulates neural stem cell proliferation and differentiation in the premature brain.
      Authors: Sun J, Sha B, Zhou W, Yang Y
      Biochem. Biophys. Res. Commun., 2010;394(1):146-52.
      Species: Human
      Sample Type: Cell Culture Supernates
    124. Age-dependent mobilization of circulating endothelial progenitor cells in infants and young children undergoing cardiac surgery with cardiopulmonary bypass.
      Authors: Sun Y, Yi D, Wang Y, Zheng R, Sun G, Wang J, Liu Y, Ren J, Wang Y, Zhang S, Gu C, Pei J
      Cytokine, 2009;47(3):206-13.
      Species: Human
      Sample Type: Plasma
    125. A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108.
      Authors: Stopeck AT, Unger JM, Rimsza LM, Bellamy WT, Iannone M, Persky DO, Leblanc M, Fisher RI, Miller TP
      Leuk. Lymphoma, 2009;50(5):728-35.
      Species: Human
      Sample Type: Urine
    126. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.
      Authors: Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, Sierra R, Ochoa AC
      Cancer Res., 2009;69(4):1553-60.
      Species: Human
      Sample Type: Plasma
    127. Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.
      Authors: Lucio-Eterovic AK, Piao Y, de Groot JF
      Clin. Cancer Res., 2009;15(14):4589-99.
      Species: Human
      Sample Type: Cell Culture Supernates
    128. Hyperoxia disrupts vascular endothelial growth factor-nitric oxide signaling and decreases growth of endothelial colony-forming cells from preterm infants.
      Authors: Fujinaga H, Baker CD, Ryan SL, Markham NE, Seedorf GJ, Balasubramaniam V, Abman SH
      Am. J. Physiol. Lung Cell Mol. Physiol., 2009;297(6):L1160-9.
      Species: Human
      Sample Type: Cell Culture Supernates
    129. Cytokine secretion by human mesenchymal stem cells cocultured with damaged corneal epithelial cells.
      Authors: Oh JY, Kim MK, Shin MS, Wee WR, Lee JH
      Cytokine, 2009;46(1):100-3.
      Species: Human
      Sample Type: Cell Culture Supernates
    130. Colorectal resection is associated with persistent proangiogenic plasma protein changes: postoperative plasma stimulates in vitro endothelial cell growth, migration, and invasion.
      Authors: Shantha Kumara HM, Feingold D, Kalady M, Dujovny N, Senagore A, Hyman N, Cekic V, Whelan RL
      Ann. Surg., 2009;249(6):973-7.
      Species: Human
      Sample Type: Plasma
    131. Vascular endothelial growth factor drives autocrine epithelial cell proliferation and survival in chronic rhinosinusitis with nasal polyposis.
      Authors: Lee HS, Myers A, Kim J
      Am. J. Respir. Crit. Care Med., 2009;180(11):1056-67.
      Species: Human
      Sample Type: nasal lavage
    132. Effects of the menstrual cycle on lung function variables in women with asthma.
      Authors: Farha S, Asosingh K, Laskowski D, Hammel J, Dweik RA, Wiedemann HP, Erzurum SC
      Am. J. Respir. Crit. Care Med., 2009;180(4):304-10.
      Species: Human
      Sample Type: Serum
    133. A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway.
      Authors: Zhu W, Ou Y, Li Y, Xiao R, Shu M, Zhou Y, Xie J, He S, Qiu P, Yan G
      Mol. Pharmacol., 2009;75(4):812-9.
      Species: Human
      Sample Type: Cell Culture Supernates
    134. Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors.
      Authors: Serefhanoglu S, Goker H, Buyukasik Y, Turgut M, Sayinalp N, Haznedaroglu IC, Aksu S, Akman U, Ozcebe OI
      Ann. Hematol., 2009;88(7):667-71.
      Species: Human
      Sample Type: Plasma
    135. Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery.
      Authors: Li Z, Van Bergen T, Van de Veire S, Van de Vel I, Moreau H, Dewerchin M, Maudgal PC, Zeyen T, Spileers W, Moons L, Stalmans I
      Invest. Ophthalmol. Vis. Sci., 2009;50(11):5217-25.
      Species: Human
      Sample Type: Aqueous humor
    136. Inhibition of complement and CD14 attenuates the Escherichia coli-induced inflammatory response in porcine whole blood.
      Authors: Thorgersen EB, Pharo A, Haverson K, Axelsen AK, Gaustad P, Kotwal GJ, Sfyroera G, Mollnes TE
      Infect. Immun., 2009;77(2):725-32.
      Species: Porcine
      Sample Type: Whole Blood
    137. Interleukin-32 promotes osteoclast differentiation but not osteoclast activation.
      Authors: Mabilleau G, Sabokbar A
      PLoS ONE, 2009;4(1):e4173.
      Species: Human
      Sample Type: Cell Culture Supernates
    138. Are plasma VEGF and its soluble receptor sFlt-1 atherogenic risk factors? Cross-sectional data from the SAPHIR study.
      Authors: Sandhofer A, Tatarczyk T, Kirchmair R, Iglseder B, Paulweber B, Patsch JR, Schratzberger P
      Atherosclerosis, 2009;206(1):265-9.
      Species: Human
      Sample Type: Plasma
    139. Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: a rationale for OHSS reduction.
      Authors: Cerrillo M, Rodriguez S, Mayoral M, Pacheco A, Martinez-Salazar J, Garcia-Velasco JA
      Fertil. Steril., 2009;91(4):1526-8.
      Species: Human
      Sample Type: Plasma
    140. Endometrial NK cells are special immature cells that await pregnancy.
      Authors: Manaster I, Mizrahi S, Goldman-Wohl D, Sela HY, Stern-Ginossar N, Lankry D, Gruda R, Hurwitz A, Bdolah Y, Haimov-Kochman R, Yagel S, Mandelboim O
      J. Immunol., 2008;181(3):1869-76.
      Species: Human
      Sample Type: Cell Culture Supernates
    141. Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients.
      Authors: van der Heijden M, van Nieuw Amerongen GP, Koolwijk P, van Hinsbergh VW, Groeneveld AB
      Thorax, 2008;63(10):903-9.
      Species: Human
      Sample Type: Plasma
    142. Hypoxia induces leptin gene expression and secretion in human preadipocytes: differential effects of hypoxia on adipokine expression by preadipocytes.
      Authors: Wang B, Wood IS, Trayhurn P
      J. Endocrinol., 2008;198(1):127-34.
      Species: Human
      Sample Type: Cell Culture Supernates
    143. Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function.
      Authors: Marcondes AM, Mhyre AJ, Stirewalt DL, Kim SH, Dinarello CA, Deeg HJ
      Proc. Natl. Acad. Sci. U.S.A., 2008;105(8):2865-70.
      Species: Human
      Sample Type: Bone Marrow Plasma
    144. Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis.
      Authors: Gutman G, Barak V, Maslovitz S, Amit A, Lessing JB, Geva E
      Fertil. Steril., 2008;89(4):922-6.
      Species: Human
      Sample Type: Serum
    145. Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
      Authors: Burstein HJ, Elias AD, Rugo HS, Cobleigh MA, Wolff AC, Eisenberg PD, Lehman M, Adams BJ, Bello CL, DePrimo SE, Baum CM, Miller KD
      J. Clin. Oncol., 2008;26(11):1810-6.
      Species: Human
      Sample Type: Plasma
    146. Isolation and characterization of CD146+ multipotent mesenchymal stromal cells.
      Authors: Sorrentino A, Ferracin M, Castelli G, Biffoni M, Tomaselli G, Baiocchi M, Fatica A, Negrini M, Peschle C, Valtieri M
      Exp. Hematol., 2008;36(8):1035-46.
      Species: Human
      Sample Type: Cell Culture Supernates
    147. Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: efficiency and possible additional pathways.
      Authors: Klettner A, Roider J
      Invest. Ophthalmol. Vis. Sci., 2008;49(10):4523-7.
      Species: Porcine
      Sample Type: Cell Culture Supernates
    148. Tissue inhibitor of metalloproteinase-3 via oncolytic herpesvirus inhibits tumor growth and vascular progenitors.
      Authors: Mahller YY, Vaikunth SS, Ripberger MC, Baird WH, Saeki Y, Cancelas JA, Crombleholme TM, Cripe TP
      Cancer Res., 2008;68(4):1170-9.
      Species: Human
      Sample Type: Plasma
    149. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
      Authors: Simiantonaki N, Jayasinghe C, Michel-Schmidt R, Peters K, Hermanns MI, Kirkpatrick CJ
      Int. J. Oncol., 2008;32(3):585-92.
      Species: Human
      Sample Type: Cell Culture Supernates
    150. Vascular endothelial growth factor-A stimulates Snail expression in breast tumor cells: implications for tumor progression.
      Authors: Wanami LS, Chen HY, Peiro S, Garcia de Herreros A, Bachelder RE
      Exp. Cell Res., 2008;314(13):2448-53.
      Species: Human
      Sample Type: Cell Lysates
    151. Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents.
      Authors: Shaked Y, Henke E, Roodhart JM, Mancuso P, Langenberg MH, Colleoni M, Daenen LG, Man S, Xu P, Emmenegger U, Tang T, Zhu Z, Witte L, Strieter RM, Bertolini F, Voest EE, Benezra R, Kerbel RS
      Cancer Cell, 2008;14(3):263-73.
    152. Pulmonary arterial hypertension and left-sided heart disease in sickle cell disease: clinical characteristics and association with soluble adhesion molecule expression.
      Authors: Klings ES, Anton Bland D, Rosenman D, Princeton S, Odhiambo A, Li G, Bernard SA, Steinberg MH, Farber HW
      Am. J. Hematol., 2008;83(7):547-53.
      Species: Human
      Sample Type: Plasma
    153. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
      Authors: Ebos JM, Lee CR, Bogdanovic E, Alami J, Van Slyke P, Francia G, Xu P, Mutsaers AJ, Dumont DJ, Kerbel RS
      Cancer Res., 2008;68(2):521-9.
      Species: Human
      Sample Type: Cell Culture Supernates
    154. Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers.
      Authors: Shariat SF, Karam JA, Walz J, Roehrborn CG, Montorsi F, Margulis V, Saad F, Slawin KM, Karakiewicz PI
      Clin. Cancer Res., 2008;14(12):3785-91.
      Species: Human
      Sample Type: Plasma
    155. Oncogenic and angiogenic growth factors accumulate during routine storage of apheresis platelet concentrates.
      Authors: Kanter J, Khan SY, Kelher M, Gore L, Silliman CC
      Clin. Cancer Res., 2008;14(12):3942-7.
      Species: Human
      Sample Type: Platelet-Poor Plasma
    156. Urinary biomarkers predict brain tumor presence and response to therapy.
      Authors: Smith ER, Zurakowski D, Saad A, Scott RM, Moses MA
      Clin. Cancer Res., 2008;14(8):2378-86.
      Species: Human
      Sample Type: Urine
    157. Neural stem/progenitor cells promote endothelial cell morphogenesis and protect endothelial cells against ischemia via HIF-1alpha-regulated VEGF signaling.
      Authors: Roitbak T, Li L, Cunningham LA
      J. Cereb. Blood Flow Metab., 2008;28(9):1530-42.
      Species: Human
      Sample Type: Cell Culture Supernates
    158. Late outgrowth endothelial progenitor cells in patients with age-related macular degeneration.
      Authors: Thill M, Strunnikova NV, Berna MJ, Gordiyenko N, Schmid K, Cousins SW, Thompson DJ, Csaky KG
      Invest. Ophthalmol. Vis. Sci., 2008;49(6):2696-708.
      Species: Human
      Sample Type: Plasma
    159. Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease.
      Authors: Findley CM, Mitchell RG, Duscha BD, Annex BH, Kontos CD
      J. Am. Coll. Cardiol., 2008;52(5):387-93.
      Species: Human
      Sample Type: Plasma
    160. Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy.
      Authors: Westerweel PE, Visseren FL, Hajer GR, Olijhoek JK, Hoefer IE, de Bree P, Rafii S, Doevendans PA, Verhaar MC
      Eur. Heart J., 2008;29(22):2808-17.
      Species: Human
      Sample Type: Serum
    161. Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma?
      Authors: Ganter MT, Cohen MJ, Brohi K, Chesebro BB, Staudenmayer KL, Rahn P, Christiaans SC, Bir ND, Pittet JF
      Ann. Surg., 2008;247(2):320-6.
      Species: Human
      Sample Type: Plasma
    162. VEGF-D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinoma.
      Authors: Thelen A, Scholz A, Benckert C, Von Marschall Z, Schroder M, Wiedenmann B, Neuhaus P, Rosewicz S, Jonas S
      Int. J. Cancer, 2008;122(11):2471-81.
      Species: Human
      Sample Type: Cell Culture Supernates
    163. Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer.
      Authors: Holmes CE, Huang JC, Pace TR, Howard AB, Muss HB
      Clin. Cancer Res., 2008;14(10):3070-6.
      Species: Human
      Sample Type: Plasma
    164. Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.
      Authors: Rini BI, Michaelson MD, Rosenberg JE, Bukowski RM, Sosman JA, Stadler WM, Hutson TE, Margolin K, Harmon CS, DePrimo SE, Kim ST, Chen I, George DJ
      J. Clin. Oncol., 2008;26(22):3743-8.
      Species: Human
      Sample Type: Plasma
    165. Structural stability of neoangiogenic intramyocardial microvessels supports functional recovery in chronic ischemic myocardium.
      Authors: Shim WS, Lim SY, Li SQ, Gu Y, Ong HC, Song IC, Chuah SC, Wong P
      J. Mol. Cell. Cardiol., 2008;45(1):70-80.
      Species: Porcine
      Sample Type: Tissue Homogenates
    166. Aggressive melanoma cells escape from BMP7-mediated autocrine growth inhibition through coordinated Noggin upregulation.
      Authors: Hsu MY, Rovinsky SA, Lai CY, Qasem S, Liu X, How J, Engelhardt JF, Murphy GF
      Lab. Invest., 2008;88(8):842-55.
      Species: Human
      Sample Type: Cell Lysates
    167. Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria.
      Authors: Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, Piera K, Price RN, Duffull SB, Celermajer DS, Anstey NM
      Proc. Natl. Acad. Sci. U.S.A., 2008;105(44):17097-102.
      Species: Human
      Sample Type: Plasma
    168. Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma.
      Authors: Kamstock D, Elmslie R, Thamm D
      Cancer Immunol. Immunother., 2007;56(8):1299-309.
      Species: Canine
      Sample Type: Plasma
    169. Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth.
      Authors: Laakkonen P, Waltari M, Holopainen T, Takahashi T, Pytowski B, Steiner P, Hicklin D, Persaud K, Tonra JR, Witte L, Alitalo K
      Cancer Res., 2007;67(2):593-9.
      Species: Human
      Sample Type: Cell Culture Supernates
    170. Serum angiopoietin-2 as a clinical marker for lung cancer.
      Authors: Park JH, Park KJ, Kim YS, Sheen SS, Lee KS, Lee HN, Oh YJ, Hwang SC
      Chest, 2007;132(1):200-6.
      Species: Human
      Sample Type: Serum
    171. Expression of Tie-2 and other receptors for endothelial growth factors in acute myeloid leukemias is associated with monocytic features of leukemic blasts.
      Authors: Riccioni R, Diverio D, Mariani G, Buffolino S, Riti V, Saulle E, Petrucci E, Cedrone M, Lo-Coco F, Foa R, Peschle C, Testa U
      Stem Cells, 2007;25(8):1862-71.
      Species: Human
      Sample Type: Cell Culture Supernates
    172. The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesis.
      Authors: Colla S, Tagliaferri S, Morandi F, Lunghi P, Donofrio G, Martorana D, Mancini C, Lazzaretti M, Mazzera L, Ravanetti L, Bonomini S, Ferrari L, Miranda C, Ladetto M, Neri TM, Neri A, Greco A, Mangoni M, Bonati A, Rizzoli V, Giuliani N
      Blood, 2007;110(13):4464-75.
      Species: Human
      Sample Type: Plasma
    173. Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis?
      Authors: Choudhury A, Freestone B, Patel J, Lip GY
      Chest, 2007;132(6):1913-9.
      Species: Human
      Sample Type: Plasma
    174. Plasma angiogenin levels in acute coronary syndromes: implications for prognosis.
      Authors: Tello-Montoliu A, Marin F, Patel J, Roldan V, Mainar L, Vicente V, Sogorb F, Lip GY
      Eur. Heart J., 2007;28(24):3006-11.
      Species: Human
      Sample Type: Plasma
    175. Tumor necrosis factor alpha as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose.
      Authors: Harrison ML, Obermueller E, Maisey NR, Hoare S, Edmonds K, Li NF, Chao D, Hall K, Lee C, Timotheadou E, Charles K, Ahern R, King DM, Eisen T, Corringham R, DeWitte M, Balkwill F, Gore M
      J. Clin. Oncol., 2007;25(29):4542-9.
      Species: Human
      Sample Type: Plasma
    176. Serum concentrations of angiogenic cytokines in Waldenstrom macroglobulinaemia: the ration of angiopoietin-1 to angiopoietin-2 and angiogenin correlate with disease severity.
      Authors: Anagnostopoulos A, Eleftherakis-Papaiakovou V, Kastritis E, Tsionos K, Bamias A, Meletis J, Dimopoulos MA, Terpos E
      Br. J. Haematol., 2007;137(6):560-8.
      Species: Human
      Sample Type: Serum
    177. Endostatin variations in childhood acute lymphoblastic leukaemia--comparison with basic fibroblast growth factor and vascular endothelial growth factor.
      Authors: Schneider P, Vasse M, Corbiere C, Legrand E, Marie-Cardine A, Boquet C, Cazin L, Vannier JP
      Leuk. Res., 2007;31(5):629-38.
      Species: Human
      Sample Type: Plasma
    178. Tissue engineering for full-thickness burns: a dermal substitute from bench to bedside.
      Authors: Kellouche S, Martin C, Korb G, Rezzonico R, Bouard D, Benbunan M, Dubertret L, Soler C, Legrand C, Dosquet C
      Biochem. Biophys. Res. Commun., 2007;363(3):472-8.
      Species: Human
      Sample Type: Cell Culture Supernates
    179. Roles of angiopoietin-1 and angiopoietin-2 on airway microvascular permeability in asthmatic patients.
      Authors: Kanazawa H, Nomura S, Asai K
      Chest, 2007;131(4):1035-41.
      Species: Human
      Sample Type: Sputum
    180. Vascular endothelial growth factor is up-regulated after status epilepticus and protects against seizure-induced neuronal loss in hippocampus.
      Authors: Nicoletti JN, Shah SK, McCloskey DP, Goodman JH, Elkady A, Atassi H, Hylton D, Rudge JS, Scharfman HE, Croll SD
      Neuroscience, 2007;151(1):232-41.
      Species: Rat
      Sample Type: Tissue Homogenates
    181. Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia.
      Authors: Lee CY, Tien HF, Hu CY, Chou WC, Lin LI
      Br. J. Cancer, 2007;97(7):877-82.
      Species: Human
      Sample Type: Plasma
    182. Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation.
      Authors: Coupel S, Moreau A, Hamidou M, Horejsi V, Soulillou JP, Charreau B
      Blood, 2007;109(7):2806-14.
      Species: Human
      Sample Type: Serum
    183. The levels of steroid hormones and cytokines in individual follicles are not associated with the fertilization outcome after intracytoplasmic sperm injection.
      Authors: Asimakopoulos B, Abu-Hassan D, Metzen E, Al-Hasani S, Diedrich K, Nikolettos N
      Fertil. Steril., 2007;90(1):60-4.
      Species: Human
      Sample Type: Follicular Fluid
    184. Airway remodeling and lack of bronchodilator response in steroid-resistant asthma.
      Authors: Goleva E, Hauk PJ, Boguniewicz J, Martin RJ, Leung DY
      J. Allergy Clin. Immunol., 2007;120(5):1065-72.
      Species: Human
      Sample Type: BALF
    185. Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro.
      Authors: Potapova IA, Gaudette GR, Brink PR, Robinson RB, Rosen MR, Cohen IS, Doronin SV
      Stem Cells, 2007;25(7):1761-8.
      Species: Human
      Sample Type: Cell Culture Supernates
    186. Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy.
      Authors: Saltz LB, Rosen LS, Marshall JL, Belt RJ, Hurwitz HI, Eckhardt SG, Bergsland EK, Haller DG, Lockhart AC, Rocha Lima CM, Huang X, DePrimo SE, Chow-Maneval E, Chao RC, Lenz HJ
      J. Clin. Oncol., 2007;25(30):4793-9.
      Species: Human
      Sample Type: Plasma
    187. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction.
      Authors: Wallner W, Sengenberger R, Strick R, Strissel PL, Meurer B, Beckmann MW, Schlembach D
      Clin. Sci., 2007;112(1):51-7.
      Species: Human
      Sample Type: Serum
    188. Phase I clinical and pharmacodynamic evaluation of oral CI-1033 in patients with refractory cancer.
      Authors: Zinner RG, Nemunaitis J, Eiseman I, Shin HJ, Olson SC, Christensen J, Huang X, Lenehan PF, Donato NJ, Shin DM
      Clin. Cancer Res., 2007;13(10):3006-14.
      Species: Human
      Sample Type: Plasma
    189. Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis.
      Authors: Siddiqui S, Sutcliffe A, Shikotra A, Woodman L, Doe C, McKenna S, Wardlaw A, Bradding P, Pavord I, Brightling C
      J. Allergy Clin. Immunol., 2007;120(4):813-9.
      Species: Human
      Sample Type: Sputum
    190. Blood-based biomarkers of SU11248 activity and clinical outcome in patients with metastatic imatinib-resistant gastrointestinal stromal tumor.
      Authors: Norden-Zfoni A, Desai J, Manola J, Beaudry P, Force J, Maki R, Folkman J, Bello C, Baum C, DePrimo SE, Shalinsky DR, Demetri GD, Heymach JV
      Clin. Cancer Res., 2007;13(9):2643-50.
      Species: Human
      Sample Type: Plasma
    191. Increased circulating endothelial progenitor cells in septic patients: correlation with survival.
      Authors: Rafat N, Hanusch C, Brinkkoetter PT, Schulte J, Brade J, Zijlstra JG, van der Woude FJ, van Ackern K, Yard BA, Beck GCh
      Crit. Care Med., 2007;35(7):1677-84.
      Species: Human
      Sample Type: Serum
    192. Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma.
      Authors: Kleinman ME, Greives MR, Churgin SS, Blechman KM, Chang EI, Ceradini DJ, Tepper OM, Gurtner GC
      Arterioscler. Thromb. Vasc. Biol., 2007;27(12):2664-70.
      Species: Human
      Sample Type: Plasma
    193. Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer.
      Authors: Caine GJ, Stonelake PS, Lip GY, Blann AD
      Cancer Lett., 2007;248(1):131-6.
      Species: Human
      Sample Type: Plasma
    194. Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients.
      Authors: Caine GJ, Ryan P, Lip GY, Blann AD
      Cancer Lett., 2007;251(2):296-301.
      Species: Human
      Sample Type: Plasma
    195. Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer.
      Authors: Kut C, Mac Gabhann F, Popel AS
      Br. J. Cancer, 2007;97(7):978-85.
      Species: Human
      Sample Type: Serum
    196. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
      Authors: Fearon U, Mullan R, Markham T, Connolly M, Sullivan S, Poole AR, FitzGerald O, Bresnihan B, Veale DJ
      Arthritis Rheum., 2006;54(10):3152-62.
      Species: Human
      Sample Type: Cell Culture Supernates
    197. Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: correlation with the extent of angiogenesis and disease-progression risk in early disease.
      Authors: Molica S, Vitelli G, Mirabelli R, Digiesu G, Giannarelli D, Cuneo A, Ribatti D, Vacca A
      Leuk. Lymphoma, 2006;47(6):1034-40.
      Species: Human
      Sample Type: Serum
    198. The potential of adiponectin in driving arthritis.
      Authors: Ehling A, Schaffler A, Herfarth H, Tarner IH, Anders S, Distler O, Paul G, Distler J, Gay S, Scholmerich J, Neumann E, Muller-Ladner U
      J. Immunol., 2006;176(7):4468-78.
      Species: Human
      Sample Type: Cell Culture Supernates
    199. Dendritic cells can turn CD4+ T lymphocytes into vascular endothelial growth factor-carrying cells by intercellular neuropilin-1 transfer.
      Authors: Bourbie-Vaudaine S, Blanchard N, Hivroz C, Romeo PH
      J. Immunol., 2006;177(3):1460-9.
      Species: Human
      Sample Type: Cell Culture Supernates
    200. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis.
      Authors: Masuyama H, Suwaki N, Nakatsukasa H, Masumoto A, Tateishi Y, Hiramatrsu Y
      Am. J. Obstet. Gynecol., 2006;194(2):551-6.
      Species: Human
      Sample Type: Serum
    201. Mast cell beta-tryptase selectively cleaves eotaxin and RANTES and abrogates their eosinophil chemotactic activities.
      Authors: Pang L, Nie M, Corbett L, Sutcliffe A, Knox AJ
      J. Immunol., 2006;176(6):3788-95.
      Species: Human
      Sample Type: Cell Culture Supernates
    202. A phase I biological and pharmacologic study of the heparanase inhibitor PI-88 in patients with advanced solid tumors.
      Authors: Basche M, Gustafson DL, Holden SN, O'Bryant CL, Gore L, Witta S, Schultz MK, Morrow M, Levin A, Creese BR, Kangas M, Roberts K, Nguyen T, Davis K, Addison RS, Moore JC, Eckhardt SG
      Clin. Cancer Res., 2006;12(18):5471-80.
      Species: Human
      Sample Type: Plasma
    203. Changes in the circulating plasma levels of VEGF and VEGF-D after adjuvant chemotherapy in patients with breast cancer and 1 to 3 positive lymph nodes.
      Authors: Kummel S, Eggemann H, Luftner D, Thomas A, Jeschke S, Zerfel N, Heilmann V, Emons G, Zeiser T, Ulm K, Kobl M, Korlach S, Schmid P, Sehouli J, Elling D, Blohmer JU
      Anticancer Res., 2006;26(2):1719-26.
      Species: Human
      Sample Type: Plasma
    204. Thiol regulation of vascular endothelial growth factor-A and its receptors in human retinal pigment epithelial cells.
      Authors: Sreekumar PG, Kannan R, de Silva AT, Burton R, Ryan SJ, Hinton DR
      Biochem. Biophys. Res. Commun., 2006;346(4):1200-6.
      Species: Human
      Sample Type: Cell Culture Supernates
    205. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice.
      Authors: Rofstad EK, Mathiesen B, Kindem K, Galappathi K
      Cancer Res., 2006;66(13):6699-707.
      Species: Human
      Sample Type: Cell Culture Supernates
    206. Humoral and cellular factors responsible for coronary collateral formation.
      Authors: Sherman JA, Hall A, Malenka DJ, De Muinck ED, Simons M
      Am. J. Cardiol., 2006;98(9):1194-7.
      Species: Human
      Sample Type: Plasma
    207. Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization.
      Authors: van Eeden PE, Tee LB, Lukehurst S, Lai CM, Rakoczy EP, Beazley LD, Dunlop SA
      Invest. Ophthalmol. Vis. Sci., 2006;47(10):4638-45.
      Species: Human
      Sample Type: ocular fluid
    208. Celecoxib up-regulates the expression of the zeta chain of T cell receptor complex in tumor-infiltrating lymphocytes in human cervical cancer.
      Authors: Ferrandina G, Ranelletti FO, Legge F, Salutari V, Martinelli E, Fattorossi A, Lorusso D, Zannoni G, Vellone V, Paglia A, Scambia G
      Clin. Cancer Res., 2006;12(7):2055-60.
      Species: Human
      Sample Type: Serum
    209. Quantitative assessment of growth factors in reaming aspirate, iliac crest, and platelet preparation.
      Authors: Herrmann S, Green J, Weber T, Scharfenberger A
      Bone, 2006;39(5):1156-63.
      Species: Human
      Sample Type: Tissue Homogenates
    210. Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.
      Authors: Kulke MH, Bergsland EK, Ryan DP, Enzinger PC, Lynch TJ, Zhu AX, Meyerhardt JA, Heymach JV, Fogler WE, Sidor C, Michelini A, Kinsella K, Venook AP, Fuchs CS
      J. Clin. Oncol., 2006;24(22):3555-61.
      Species: Human
      Sample Type: Urine
    211. Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs.
      Authors: Hirata A, Minamino T, Asanuma H, Fujita M, Wakeno M, Myoishi M, Tsukamoto O, Okada K, Koyama H, Komamura K, Takashima S, Shinozaki Y, Mori H, Shiraga M, Kitakaze M, Hori M
      J. Am. Coll. Cardiol., 2006;48(1):176-84.
      Species: Canine
      Sample Type: Plasma
    212. Over-expression of p53 mutants in LNCaP cells alters tumor growth and angiogenesis in vivo.
      Authors: Perryman LA, Blair JM, Kingsley EA, Szymanska B, Ow KT, Wen VW, MacKenzie KL, Vermeulen PB, Jackson P, Russell PJ
      Biochem. Biophys. Res. Commun., 2006;345(3):1207-14.
      Species: Human
      Sample Type: Cell Culture Supernates
    213. Effects of simvastatin on angiogenic growth factors released at the site of microvascular injury.
      Authors: Undas A, Celinska-Lowenhoff M, Stepien E, Nizankowski R, Tracz W, Szczeklik A
      Thromb. Haemost., 2006;95(6):1045-7.
      Species: Human
      Sample Type: Plasma
    214. Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction.
      Authors: Iwama H, Uemura S, Naya N, Imagawa K, Takemoto Y, Asai O, Onoue K, Okayama S, Somekawa S, Kida Y, Takeda Y, Nakatani K, Takaoka M, Kawata H, Horii M, Nakajima T, Doi N, Saito Y
      J. Am. Coll. Cardiol., 2006;47(8):1559-67.
      Species: Human
      Sample Type: Plasma
    215. Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma.
      Authors: Lee KS, Min KH, Kim SR, Park SJ, Park HS, Jin GY, Lee YC
      Am. J. Respir. Crit. Care Med., 2006;174(2):161-70.
      Species: Human
      Sample Type: BALF
    216. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells.
      Authors: Moreno MJ, Ball M, Andrade MF, McDermid A, Stanimirovic DB
      Glia, 2006;53(8):845-57.
      Species: Human
      Sample Type: Cell Culture Supernates
    217. Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells.
      Authors: Lederle W, Stark HJ, Skobe M, Fusenig NE, Mueller MM
      Am. J. Pathol., 2006;169(5):1767-83.
      Species: Human
      Sample Type: Cell Culture Supernates
    218. Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivo.
      Authors: Li L, Lin X, Staver M, Shoemaker A, Semizarov D, Fesik SW, Shen Y
      Cancer Res., 2005;65(16):7249-58.
      Species: Human
      Sample Type: Cell Culture Supernates
    219. Hyperbaric oxygen and ovarian follicular stimulation for in vitro fertilization: a pilot study.
      Authors: Van Voorhis BJ, Greensmith JE, Dokras A, Sparks AE, Simmons ST, Syrop CH
      Fertil. Steril., 2005;83(1):226-8.
      Species: Human
      Sample Type: Follicular Fluid
    220. Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours.
      Authors: Mross K, Drevs J, Muller M, Medinger M, Marme D, Hennig J, Morgan B, Lebwohl D, Masson E, Ho YY, Gunther C, Laurent D, Unger C
      Eur. J. Cancer, 2005;41(9):1291-9.
      Species: Human
      Sample Type: Plasma
    221. A potential role for vascular endothelial growth factor-D as an autocrine growth factor for human breast carcinoma cells.
      Authors: Akahane M, Akahane T, Shah A, Okajima E, Thorgeirsson UP
      Anticancer Res., 2005;25(2):701-7.
      Species: Human
      Sample Type: Cell Culture Supernates
    222. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
      Authors: Watanabe D, Suzuma K, Suzuma I, Ohashi H, Ojima T, Takagi H
      Am. J. Ophthalmol., 2005;139(3):476-81.
      Species: Human
      Sample Type: Vitreous Humor
    223. Antibody neutralization of vascular endothelial growth factor (VEGF) fails to attenuate vascular permeability and brain edema in experimental pneumococcal meningitis.
      Authors: van der Flier M, Coenjaerts FE, Mwinzi PN, Rijkers E, Ruyken M, Scharringa J, Kimpen JL, Hoepelman AI, Geelen SP
      J. Neuroimmunol., 2005;160(1):170-7.
      Species: Rabbit
      Sample Type: CSF
    224. Genetic and clinical factors influence the baseline permeability of the peritoneal membrane.
      Authors: Gillerot G, Goffin E, Michel C, Evenepoel P, Biesen WV, Tintillier M, Stenvinkel P, Heimburger O, Lindholm B, Nordfors L, Robert A, Devuyst O
      Kidney Int., 2005;67(6):2477-87.
      Species: Human
      Sample Type: Plasma
    225. Urinary placental growth factor and risk of preeclampsia.
      Authors: Levine RJ, Thadhani R, Qian C, Lam C, Lim KH, Yu KF, Blink AL, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA
      JAMA, 2005;293(1):77-85.
      Species: Human
      Sample Type: Urine
    226. Platelet-derived growth factor-AA is an essential and autocrine regulator of vascular endothelial growth factor expression in non-small cell lung carcinomas.
      Authors: Shikada Y, Yonemitsu Y, Koga T, Onimaru M, Nakano T, Okano S, Sata S, Nakagawa K, Yoshino I, Maehara Y, Sueishi K
      Cancer Res., 2005;65(16):7241-8.
      Species: Human
      Sample Type: Cell Culture Supernates
    227. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
      Authors: Buhimschi CS, Norwitz ER, Funai E, Richman S, Guller S, Lockwood CJ, Buhimschi IA
      Am. J. Obstet. Gynecol., 2005;192(3):734-41.
      Species: Human
      Sample Type: Urine
    228. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis.
      Authors: Numasaki M, Watanabe M, Suzuki T, Takahashi H, Nakamura A, McAllister F, Hishinuma T, Goto J, Lotze MT, Kolls JK, Sasaki H
      J. Immunol., 2005;175(9):6177-89.
      Species: Human
      Sample Type: Cell Culture Supernates
    229. Tumor necrosis factor alpha and adiponectin in bone marrow interstitial fluid from patients with acute myeloid leukemia inhibit normal hematopoiesis.
      Authors: Iversen PO, Wiig H
      Clin. Cancer Res., 2005;11(19):6793-9.
      Species: Human
      Sample Type: Bone Marrow Fluid
    230. Vascular endothelial growth factor in pleural effusions of different origin.
      Authors: Sack U, Hoffmann M, Zhao XJ, Chan KS, Hui DS, Gosse H, Engelmann L, Schauer J, Emmrich F, Hoheisel G
      Eur. Respir. J., 2005;25(4):600-4.
      Species: Human
      Sample Type: Serum
    231. Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals.
      Authors: Briguori C, Testa U, Colombo A, Petrucci E, Condorelli G, Airoldi F, Peschle C, Condorelli G
      Am. J. Cardiol., 2005;97(4):472-6.
      Species: Human
      Sample Type: Serum
    232. Vascular endothelial growth factor (VEGF) levels as a tool to discriminate between malignant and nonmalignant ascites.
      Authors: Nascimento I, Schaer R, Lemaire D, Freire S, Paule B, Carvalho S, Meyer R, Schaer-Barbosa H
      APMIS, 2004;112(9):585-7.
      Species: Human
      Sample Type: Ascites
    233. High altitude training of dogs results in elevated erythropoietin and endothelin-1 serum levels.
      Authors: Glaus TM, Grenacher B, Koch D, Reiner B, Gassmann M
      Comp. Biochem. Physiol., Part A Mol. Integr. Physiol., 2004;138(3):355-61.
      Species: Canine
      Sample Type: Serum
    234. Elevated erythropoietin in vitreous with ischemic retinal diseases.
      Authors: Inomata Y, Hirata A, Takahashi E, Kawaji T, Fukushima M, Tanihara H
      Neuroreport, 2004;15(5):877-9.
      Species: Human
      Sample Type: Serum
    235. Vascular endothelial growth factor is increased in cerebrospinal fluid after traumatic brain injury in infants and children.
      Authors: Shore PM, Jackson EK, Wisniewski SR, Clark RS, Adelson PD, Kochanek PM
      Neurosurgery, 2004;54(3):605-11; discu.
      Species: Human
      Sample Type: CSF
    236. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
      Authors: Ilzecka J
      Clin Neurol Neurosurg, 2004;106(4):289-93.
      Species: Human
      Sample Type: CSF
    237. Follicular fluid concentrations of vascular endothelial growth factor, inhibin A and inhibin B in IVF cycles: are they markers for ovarian response and pregnancy outcome?
      Authors: Ocal P, Aydin S, Cepni I, Idil S, Idil M, Uzun H, Benian A
      Eur. J. Obstet. Gynecol. Reprod. Biol., 2004;115(2):194-9.
      Species: Human
      Sample Type: Follicular Fluid
    238. Antioxidant intervention prevents renal neovascularization in hypercholesterolemic pigs.
      Authors: Chade AR, Bentley MD, Zhu X, Rodriguez-Porcel M, Niemeyer S, Amores-Arriaga B, Napoli C, Ritman EL, Lerman A, Lerman LO
      J. Am. Soc. Nephrol., 2004;15(7):1816-25.
      Species: Porcine
      Sample Type: Tissue Homogenates
    239. Urine vascular endothelial growth factor-A is not a useful marker for endometriosis.
      Authors: Potlog-Nahari C, Stratton P, Winkel C, Widra E, Sinaii N, Connors S, Nieman LK
      Fertil. Steril., 2004;81(6):1507-12.
      Species: Human
      Sample Type: Urine
    240. Circulating angiogenic factors and the risk of preeclampsia.
      Authors: Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA
      N. Engl. J. Med., 2004;350(7):672-83.
      Species: Human
      Sample Type: Serum
    241. PEDF derived from glial Muller cells: a possible regulator of retinal angiogenesis.
      Authors: Eichler W, Yafai Y, Keller T, Wiedemann P, Reichenbach A
      Exp. Cell Res., 2004;299(1):68-78.
      Species: Guinea Pig
      Sample Type: Cell Culture Supernates
    242. Vascular endothelial growth factor (VEGF) concentration in sera and tumor effusions from patients with ovarian carcinoma.
      Authors: Harlozinska A, Sedlaczek P, Kulpa J, Grybos M, Wojcik E, Van Dalen A, Einarsson R
      Anticancer Res., 2004;24(2):1149-57.
      Species: Human
      Sample Type: Serum
    243. Neoadjuvant therapy and biliary decompression lower biliary and pancreatic juice vascular endothelial growth factor levels in patients with periampullary adenocarcinoma.
      Authors: Berger AC, Watson JC, Ross EA, Zalatoris A, Hoffman JP
      Am Surg, 2004;70(2):169-73; discu.
      Species: Human
      Sample Type: Plasma
    244. A potential pro-angiogenic cell therapy with human placenta-derived mesenchymal cells.
      Authors: Nishishita T, Ouchi K, Zhang X, Inoue M, Inazawa T, Yoshiura K, Kuwabara K, Nakaoka T, Watanabe N, Igura K, Takahashi TA, Yamashita N
      Biochem. Biophys. Res. Commun., 2004;325(1):24-31.
      Species: Human
      Sample Type: Cell Lysates
    245. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
      Authors: Qian DZ, Wang X, Kachhap SK, Kato Y, Wei Y, Zhang L, Atadja P, Pili R
      Cancer Res., 2004;64(18):6626-34.
      Species: Human
      Sample Type: Cell Culture Supernates
    246. Clinicopathologic correlation of progressive fibrovascular proliferation associated with occult choroidal neovascularization in age-related macular degeneration.
      Authors: Csaky K, Baffi J, Chan CC, Byrnes GA
      Arch. Ophthalmol., 2004;122(4):650-2.
      Species: Human
      Sample Type: Subretinal fluid
    247. Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation.
      Authors: Seo KH, Lee HS, Jung B, Ko HM, Choi JH, Park SJ, Choi IH, Lee HK, Im SY
      Cancer Res., 2004;64(18):6482-8.
      Species: Human
      Sample Type: Cell Culture Supernates
    248. Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone.
      Authors: Brooks HL, Caballero S, Newell CK, Steinmetz RL, Watson D, Segal MS, Harrison JK, Scott EW, Grant MB
      Arch. Ophthalmol., 2004;122(12):1801-7.
      Species: Human
      Sample Type: Vitreous Humor
    249. Reduced pericardial levels of endostatin correlate with collateral development in patients with ischemic heart disease.
      Authors: Panchal VR, Rehman J, Nguyen AT, Brown JW, Turrentine MW, Mahomed Y, March KL
      J. Am. Coll. Cardiol., 2004;43(8):1383-7.
      Species: Human
      Sample Type: Pericardial Fluid
    250. Effects of pranlukast administration on vascular endothelial growth factor levels in asthmatic patients.
      Authors: Kanazawa H, Yoshikawa T, Hirata K, Yoshikawa J
      Chest, 2004;125(5):1700-5.
      Species: Human
      Sample Type: Saliva
    251. Follicular blood flow is a better predictor of the outcome of in vitro fertilization-embryo transfer than follicular fluid vascular endothelial growth factor and nitric oxide concentrations.
      Authors: Kim KH, Oh DS, Jeong JH, Shin BS, Joo BS, Lee KS
      Fertil. Steril., 2004;82(3):586-92.
      Species: Human
      Sample Type: Follicular Fluid
    252. Hepatocyte growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy: its relationship with vascular endothelial growth factor and retinopathy activity.
      Authors: Simo R, Lecube A, Garcia-Arumi J, Carrasco E, Hernandez C
      Diabetes Care, 2004;27(1):287-8.
      Species: Human
      Sample Type: Vitreous Humor
    253. Conduction performance of collateral vessels induced by vascular endothelial growth factor or basic fibroblast growth factor.
      Authors: Kondoh K, Koyama H, Miyata T, Takato T, Hamada H, Shigematsu H
      Cardiovasc. Res., 2004;61(1):132-42.
      Species: Rabbit
      Sample Type: Cell Culture Supernates
    254. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
      Authors: Kim NH, Kim KB, Kim DL, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR
      Diabet. Med., 2004;21(6):545-51.
      Species: Human
      Sample Type: Plasma
    255. Hypoxia activates matrix metalloproteinase expression and the VEGF system in monkey choroid-retinal endothelial cells: Involvement of cytosolic phospholipase A2 activity.
      Authors: Ottino P, Finley J, Rojo E, Ottlecz A, Lambrou GN, Bazan HE, Bazan NG
      Mol. Vis., 2004;10(0):341-50.
      Species: Primate - Macaca mulatta (Rhesus monkey)
      Sample Type: Cell Culture Supernates
    256. Amniotic levels of nitric oxide and vascular endothelial growth factor in pregnancy with subsequent intrauterine fetal death.
      Authors: Tranquilli AL, Giannubilo SR, Bezzeccheri V, Ciavattini A, Scagnoli C, Mazzanti L
      Eur. J. Obstet. Gynecol. Reprod. Biol., 2004;114(2):162-5.
      Species: Human
      Sample Type: Amniotic Fluid
    257. Bi-directional cell contact-dependent regulation of gene expression between endothelial cells and osteoblasts in a three-dimensional spheroidal coculture model.
      Authors: Stahl A, Wenger A, Weber H, Stark GB, Augustin HG, Finkenzeller G
      Biochem. Biophys. Res. Commun., 2004;322(2):684-92.
      Species: Human
      Sample Type: Cell Culture Supernates
    258. Have urinary levels of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, a prognostic value in childhood acute lymphoblastic leukaemia?
      Authors: Schneider P, Vasse M, Legrand E, Callat MP, Vannier JP
      Br. J. Haematol., 2003;122(1):163-4.
      Species: Human
      Sample Type: Urine
    259. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
      Authors: Maynard SE, Min JY, Merchan J, Lim KH, Mondal S, Stillman IE, Epstein FH, Karumanchi SA
      J. Clin. Invest., 2003;111(5):649-58.
      Species: Human
      Sample Type: Serum
    260. Expansion of human SCID-repopulating cells under hypoxic conditions.
      Authors: Danet GH, Pan Y, Luongo JL, Bonnet DA, Simon MC
      J. Clin. Invest., 2003;112(1):126-35.
      Species: Human
      Sample Type: Cell Culture Supernates
    261. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
      Authors: Simo R, Lecube A, Segura RM, Garcia Arumi J, Hernandez C
      Am. J. Ophthalmol., 2002;134(3):376-82.
      Species: Human
      Sample Type: Vitreous Humor
    262. Flaxseed inhibits metastasis and decreases extracellular vascular endothelial growth factor in human breast cancer xenografts.
      Authors: Dabrosin C, Chen J, Wang L, Thompson LU
      Cancer Lett., 2002;185(1):31-7.
      Species: Human
      Sample Type: Tumor interstitial fluid
    263. Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion.
      Authors: Boyd SR, Zachary I, Chakravarthy U, Allen GJ, Wisdom GB, Cree IA, Martin JF, Hykin PG
      Arch. Ophthalmol., 2002;120(12):1644-50.
      Species: Human
      Sample Type: Plasma
    264. High basic fibroblast growth factor levels in nipple aspirate fluid are correlated with breast cancer.
      Authors: Hsiung R, Zhu W, Klein G, Qin W, Rosenberg A, Park P, Rosato E, Sauter E
      Cancer J, 2002;8(4):303-10.
      Species: Human
      Sample Type: Nipple aspirate fluid
    265. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome.
      Authors: Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C, Fisher SJ
      Am. J. Pathol., 2002;160(4):1405-23.
      Species: Human
      Sample Type: Cell Culture Supernates
    266. Intraperitoneal bispecific antibody (HEA125xOKT3) therapy inhibits malignant ascites production in advanced ovarian carcinoma.
      Authors: Marme A, Strauss G, Bastert G, Grischke EM, Moldenhauer G
      Int. J. Cancer, 2002;101(2):183-9.
      Species: Human
      Sample Type: Ascites
    267. Ovariectomy increases mitogens and platelet-induced proliferation of arterial smooth muscle.
      Authors: Bracamonte MP, Rud KS, Owen WG, Miller VM
      Am. J. Physiol. Heart Circ. Physiol., 2002;283(3):H853-60.
      Species: Porcine
      Sample Type: Cell Lysates
    268. Nitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathy.
      Authors: Hernandez C, Lecube A, Segura RM, Sararols L, Simo R
      Diabet. Med., 2002;19(8):655-60.
      Species: Human
      Sample Type: Vitreous Humor
    269. Vascular endothelial growth factor concentrations in body cavity effusions in dogs.
      Authors: Clifford CA, Hughes D, Beal MW, Henry CJ, Drobatz KJ, Sorenmo KU
      J. Vet. Intern. Med., 2002;16(2):164-8.
      Species: Canine
      Sample Type: Body effusions
    270. Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects.
      Authors: Asai K, Kanazawa H, Otani K, Shiraishi S, Hirata K, Yoshikawa J
      J. Allergy Clin. Immunol., 2002;110(4):571-5.
      Species: Human
      Sample Type: Sputum
    271. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy.
      Authors: Ogata N, Nishikawa M, Nishimura T, Mitsuma Y, Matsumura M
      Am. J. Ophthalmol., 2002;134(3):348-53.
      Species: Human
      Sample Type: Vitreous Humor
    272. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor.
      Authors: Wang TH, Horng SG, Chang CL, Wu HM, Tsai YJ, Wang HS, Soong YK
      J. Clin. Endocrinol. Metab., 2002;87(7):3300-8.
      Species: Human
      Sample Type: Serum
    273. VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression.
      Authors: George ML, Tutton MG, Janssen F, Arnaout A, Abulafi AM, Eccles SA, Swift RI
      Neoplasia, 2001;3(5):420-7.
      Species: Human
      Sample Type: Tissue Homogenates
    274. Clinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathy.
      Authors: Shinoda K, Ishida S, Kawashima S, Wakabayashi T, Uchita M, Matsuzaki T, Takayama M, Shinmura K, Yamada M
      Curr. Eye Res., 2000;21(2):655-61.
      Species: Human
      Sample Type: Aqueous humor
    275. Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo.
      Authors: Westphal JR, Van't Hullenaar R, Peek R, Willems RW, Crickard K, Crickard U, Askaa J, Clemmensen I, Ruiter DJ, De Waal RM
      Int. J. Cancer, 2000;86(6):768-76.
      Species: Human
      Sample Type: Cell Culture Supernates
    276. Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models.
      Authors: Kornowski R, Leon MB, Fuchs S, Vodovotz Y, Flynn MA, Gordon DA, Pierre A, Kovesdi I, Keiser JA, Epstein SE
      J. Am. Coll. Cardiol., 2000;35(4):1031-9.
      Species: Porcine
      Sample Type: Tissue Homogenates
    277. Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome.
      Authors: Soubrier M, Sauron C, Souweine B, Larroche C, Wechsler B, Guillevin L, Piette JC, Rousset H, Deteix P
      Am. J. Kidney Dis., 1999;34(4):633-8.
      Species: Human
      Sample Type: Serum
    278. Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval.
      Authors: Hazzard TM, Molskness TA, Chaffin CL, Stouffer RL
      Mol. Hum. Reprod., 1999;5(12):1115-21.
      Species: Primate - Macaca mulatta (Rhesus monkey)
      Sample Type: Follicular Fluid
    279. Adenosine upregulates VEGF expression in cultured myocardial vascular smooth muscle cells.
      Authors: Gu JW, Brady AL, Anand V, Moore MC, Kelly WC, Adair TH
      Am. J. Physiol., 1999;277(2):H595-602.
      Species: Canine
      Sample Type: Cell Culture Supernates
    280. Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I.
      Authors: Akagi Y, Liu W, Zebrowski B, Xie K, Ellis LM
      Cancer Res., 1998;58(17):4008-14.
      Species: Human
      Sample Type: Cell Lysates
    281. Hypoxia-induced expression of VEGF is reversible in myocardial vascular smooth muscle cells.
      Authors: Gu JW, Adair TH
      Am. J. Physiol., 1997;273(2):H628-33.
      Species: Canine
      Sample Type: Cell Culture Supernates
    282. High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFkappaB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts.
      Authors: Rudisch A, Dewhurst M, Horga L, Kramer N, Harrer N, Dong M, van der Kuip H, Wernitznig A, Bernthaler A, Dolznig H, Sommergruber W
      PLoS ONE, 0;10(4):e0124283.
      Species: Human
      Sample Type: Cell Culture Supernates
    Expand to show all
    ELISA Controls
    Description Application Cat# Citations Images  

    Quantikine Immunoassay Control Group 1

    Ctrl QC01-1
    View Sizes & Prices
    Catalog# Size Price Stock Quantity
    Loading Information....
    Supplemental ELISA Products
    Description Application Cat# Citations Images  

    Quantikine Wash Buffer 1

    ELISA WA126 5
    View Sizes & Prices
    Catalog# Size Price Stock Quantity
    Loading Information....
    Average Rating: 4.3 (Based on 3 reviews)

    Have you used Human VEGF Quantikine ELISA Kit?

    Submit a review and receive a $25 amazon gift card if you include an image - $10 Amazon card for reviews without an image. Limited to verified customers in USA, Canada and Europe.

    Read what people are saying who have used Human VEGF Quantikine ELISA Kit.

    We have 3 review tested in 1 application: Immunocytochemistry/Immunofluorescence.
    Filter by Ratings
    Excellent
    (1)
    Very Good
    (2)
    All Ratings
    Filter by Applications
    ICC/IF
    (3)
    All Applications
    Filter by Species
    All Species

    Images Ratings Applications Species Reviewed By Date Details
    Immunocytochemistry/Immunofluorescence Human VEGF Quantikine ELISA Kit DVE00
    Enlarge
    Very Good
     ICC/IF Anonymous 06/20/2016
    Show
    Image Details
    Immunocytochemistry/Immunofluorescence Human VEGF Quantikine ELISA Kit DVE00
    Immunocytochemistry/Immunofluorescence: Human VEGF Quantikine ELISA Kit [DVE00]

    Summary

    ApplicationImmunocytochemistry/Immunofluorescence
    Sample TestedAdipose tissue
    Immunocytochemistry/Immunofluorescence Human VEGF Quantikine ELISA Kit DVE00
    Enlarge
    Very Good
     ICC/IF Anonymous 06/17/2016
    Show
    Image Details
    Immunocytochemistry/Immunofluorescence Human VEGF Quantikine ELISA Kit DVE00
    Immunocytochemistry/Immunofluorescence: Human VEGF Quantikine ELISA Kit [DVE00]

    Summary

    ApplicationImmunocytochemistry/Immunofluorescence
    Sample TestedIMR-32 human neuroblastoma cell line
    Immunocytochemistry/Immunofluorescence Human VEGF Quantikine ELISA Kit DVE00
    Enlarge
    Excellent
     ICC/IF Anonymous 05/09/2016
    Show
    Image Details
    Immunocytochemistry/Immunofluorescence Human VEGF Quantikine ELISA Kit DVE00
    Immunocytochemistry/Immunofluorescence: Human VEGF Quantikine ELISA Kit [DVE00]

    Summary

    ApplicationImmunocytochemistry/Immunofluorescence
    Sample TestedBone Putty

    FAQs

    1. Does the Human VEGF Quantikine® ELISA kit (Catalog # DVE00) detect mouse VEGF?

      • No, the kit does not detect mouse VEGF. Specificity testing with recombinant mouse VEGF 120 and VEGF 164 showed no cross-reactivity. For the detection of mouse VEGF, please refer to the Mouse VEGF Quantikine® ELISA kit (Catalog # MMV00).

    2. Does the Human VEGF Quantikine® ELISA kit (Catalog # DVE00) detect porcine samples?

      • Our lab has not tested porcine samples in the kit, however many customers have published use of the kit with porcine samples.  Links to these references can be found in the citations tab by selecting for Porcine in the Species filter.

    3. Does the Human VEGF Quantikine® ELISA kit (Catalog # DVE00) detect human VEGF121?

      • Yes, the kit detects VEGF121.  In specificity testing, 100% cross-reactivity was observed with recombinant human VEGF121

    4. Is the heterodimer VEGF165/PlGF detected by DVE00

      • VEGF165/PlGF is not detected by this kit. Recombinant human VEGF165/PlGF was prepared at 50 ng/mL and assayed for cross-reactivity, with negative results.

    5. Is there a protocol for using cell lysates with the Human VEGF Quantikine® ELISA Kit (Catalog # DVE00)?

      • R&D Systems does not have a validated cell lysate protocol available for this kit.  However, many customers have published use of the kit with cell lysates.  Links to these references can be found in the citations tab.  Generally, the use of detergents in the lysis buffer should be avoided when preparing cell samples.  A better option is to lyse the cells via freeze/thaw cycles or by sonication. 

    6. How long can samples (cell cultures, serum, and plasma) be stored and still be stable for measuring VEGF using the DVE00 Human VEGF Quantikine® ELISA Kit?

      • R&D Systems does not evaluate sample stability. Variations in sample collection, processing, and storage may affect stability of samples. It is recommend to assay sample immediately after collection when possible, or aliquot into single use volumes and store samples frozen. Avoid repeat freeze-thaw cycles with the stored samples to avoid protein degradation.

    View all ELISA FAQs

    Order Details

    Contact Information

    Certificate of Analysis Lookup

    The document you requested is not available online. Please enter the Catalog Number and Lot Number below to have a document emailed to you at the address provided

    Certificate of Analysis Lookup

    Research Areas of Interest
    R&D Systems Guarantee

    Customers Who Viewed
    This Item Also Viewed

    Feedback

    Customer Information